1
|
Valentine H, Aiken W, Morrison B, Zhao Z, Fowle H, Wasserman JS, Thompson E, Chin W, Young M, Clarke S, Gibbs D, Harrison S, McLaughlin W, Kwok T, Jin F, Campbell KS, Horvath A, Thompson R, Lee NH, Zhou Y, Graña X, Ragin C, Badal S. Expanding the prostate cancer cell line repertoire with ACRJ-PC28, an AR-negative neuroendocrine cell line derived from an African-Caribbean patient. Cancer Res Commun 2022; 2:1355-1371. [PMID: 36643868 PMCID: PMC9836004 DOI: 10.1158/2767-9764.crc-22-0245] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Prostate cell lines from diverse backgrounds are important to addressing disparities in prostate cancer (PCa) incidence and mortality rates among Black men. ACRJ-PC28 was developed from a transrectal needle biopsy and established via inactivation of the CDKN2A locus and simultaneous expression of human telomerase. Characterization assays included growth curve analysis, immunoblots, IHC, 3D cultures, immunofluorescence imaging, confocal microscopy, flow cytometry, WGS, and RNA-Seq. ACRJ-PC28 has been passaged more than 40 times in vitro over 10 months with a doubling time of 45 hours. STR profiling confirmed the novelty and human origin of the cell line. RNA-Seq confirmed the expression of prostate specific genes alpha-methylacyl-CoA racemase (AMACR) and NKX3.1 and Neuroendocrine specific markers synaptophysin (SYP) and enolase 2 (ENO2) and IHC confirmed the presence of AMACR. Immunoblots indicated the cell line is of basal-luminal type; expresses p53 and pRB and is AR negative. WGS confirmed the absence of exonic mutations and the presence of intronic variants that appear to not affect function of AR, p53, and pRB. RNA-Seq data revealed numerous TP53 and RB1 mRNA splice variants and the lack of AR mRNA expression. This is consistent with retention of p53 function in response to DNA damage and pRB function in response to contact inhibition. Soft agar anchorage-independent analysis indicated that the cells are transformed, confirmed by principal component analysis (PCA) where ACRJ-PC28 cells cluster alongside other PCa tumor tissues, yet was distinct. The novel methodology described should advance prostate cell line development, addressing the disparity in PCa among Black men.
Collapse
Affiliation(s)
- Henkel Valentine
- Department of Basic Medical Sciences, Faculty of Medical Sciences Teaching and Research Complex, The University of the West Indies, Mona, Jamaica, West Indies
| | - William Aiken
- Department of Surgery, Radiology, Anaesthesia and Intensive Care, Section of Surgery, Faculty of Medical Sciences, The University of the West Indies, Mona, Jamaica
- African-Caribbean Cancer Consortium, Philadelphia, Pennsylvania
| | - Belinda Morrison
- Department of Surgery, Radiology, Anaesthesia and Intensive Care, Section of Surgery, Faculty of Medical Sciences, The University of the West Indies, Mona, Jamaica
- African-Caribbean Cancer Consortium, Philadelphia, Pennsylvania
| | - Ziran Zhao
- Fels Institute for Cancer Research and Molecular Biology, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania
| | - Holly Fowle
- Fels Institute for Cancer Research and Molecular Biology, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania
| | - Jason S. Wasserman
- Fels Institute for Cancer Research and Molecular Biology, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania
| | - Elon Thompson
- Department of Urology Kingston Public Hospital, North Street, Kingston
| | - Warren Chin
- Department of Urology Kingston Public Hospital, North Street, Kingston
| | - Mark Young
- Department of Urology Kingston Public Hospital, North Street, Kingston
| | - Shannique Clarke
- Department of Basic Medical Sciences, Faculty of Medical Sciences Teaching and Research Complex, The University of the West Indies, Mona, Jamaica, West Indies
| | - Denise Gibbs
- African-Caribbean Cancer Consortium, Philadelphia, Pennsylvania
- Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania
| | - Sharon Harrison
- African-Caribbean Cancer Consortium, Philadelphia, Pennsylvania
- Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania
| | - Wayne McLaughlin
- CARIGEN, Faculty of Medical Sciences Teaching and Research Complex, The University of the West Indies, Mona, Jamaica
| | - Tim Kwok
- Cell Culture Facility, Fox Chase Cancer Center, Philadelphia, Pennsylvania
| | - Fang Jin
- Cell Culture Facility, Fox Chase Cancer Center, Philadelphia, Pennsylvania
| | - Kerry S. Campbell
- Blood Cell Development and Function Program and Cell Culture Facility, Fox Chase Cancer Center, Philadelphia, Pennsylvania
| | - Anelia Horvath
- Department of Biochemistry and Molecular Medicine, George Washington University School of Medicine and Health Sciences, Washington, District of Columbia
| | - Rory Thompson
- African-Caribbean Cancer Consortium, Philadelphia, Pennsylvania
- Department of Pathology, University Hospital of the West Indies, Mona, Kingston, Jamaica
| | - Norman H. Lee
- Department of Pharmacology and Physiology, George Washington University School of Medicine and Health Sciences, GW Cancer Center, Washington, District of Columbia
| | - Yan Zhou
- Biostatistics and Bioinformatics Facility, Fox Chase Cancer Center, Philadelphia, Pennsylvania
| | - Xavier Graña
- Fels Institute for Cancer Research and Molecular Biology, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania
| | - Camille Ragin
- African-Caribbean Cancer Consortium, Philadelphia, Pennsylvania
- Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania
| | - Simone Badal
- Department of Basic Medical Sciences, Faculty of Medical Sciences Teaching and Research Complex, The University of the West Indies, Mona, Jamaica, West Indies
- African-Caribbean Cancer Consortium, Philadelphia, Pennsylvania
- Corresponding Author: Simone Ann Marie Badal, The University of the West Indies, Mona, Kingston, Jamaica, West Indies. Phone: 876-325-7366; Fax: 876-977-9285; E-mail:
| |
Collapse
|
2
|
Blackman E, Ashing K, Gibbs D, Kuo YM, Andrews A, Ramakodi M, Devarajan K, Bucci J, Jean-Louis G, Richards-Waritay O, Wilson B, Bowen C, Edi E, Tolbert V, Noumbissi R, Cabral DN, Oliver J, Roberts R, Tulloch-Reid M, Ragin C. The Cancer Prevention Project of Philadelphia: preliminary findings examining diversity among the African diaspora. Ethn Health 2021; 26:659-675. [PMID: 30453751 PMCID: PMC6526085 DOI: 10.1080/13557858.2018.1548695] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/21/2017] [Accepted: 10/22/2018] [Indexed: 06/09/2023]
Abstract
Objective: Cancer mortality inequity among persons of African Ancestry is remarkable. Yet, Black inclusion in cancer biology research is sorely lacking and warrants urgent attention. Epidemiologic research linking African Ancestry and the African Diaspora to disease susceptibility and outcomes is critical for understanding the significant and troubling health disparities among Blacks. Therefore, in a cohort of diverse Blacks, this study examined differences in genetic ancestry informative markers (AIMs) in the DNA repair pathway and the cancer related biomarker 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL).Methods: Participants completed a questionnaire and provided bio-specimens. AIMs in or around DNA repair pathway genes were analyzed to assess differences in minor allele frequency (MAF) across the 3 ethnic subgroups. NNAL concentration in urine was measured among current smokers.Results: To date the cohort includes 852 participants, 88.3% being Black. Of the 752 Blacks, 51.3% were US-born, 27.8% were Caribbean-born, and 19.6% were Africa-born. Current and former smokers represented 14.9% and 10.0%, respectively. US-born Blacks were more likely to be smokers and poor metabolizers of NNAL. Two-way hierarchical clustering revealed MAF of AIMs differed across the 3 ethnic subgroups.Conclusion: Our findings are consistent with the emerging literature demonstrating Black heterogeneity underscoring African Ancestry genetic subgroup differences - specifically relevant to cancer. Further investigations, with data harmonization and sharing, are urgently needed to begin to map African Ancestry cancer biomarkers as well as race, and race by place\region comparative biomarkers to inform cancer prevention and treatment in the era of precision medicine.
Collapse
Affiliation(s)
- Elizabeth Blackman
- Cancer Prevention and Control Program, Fox Chase Cancer Center-Temple Health, Philadelphia, USA
- Department of Epidemiology and Biostatistics, College of Public Health, Temple University, Philadelphia, USA
- African-Caribbean Cancer Consortium, Philadelphia, USA
| | - Kimlin Ashing
- Center of Community Alliance for Research & Education, Division of Health Equity, City of Hope Medical Center, Duarte, USA
| | - Denise Gibbs
- Cancer Prevention and Control Program, Fox Chase Cancer Center-Temple Health, Philadelphia, USA
- African-Caribbean Cancer Consortium, Philadelphia, USA
| | - Yin-Ming Kuo
- Cancer Epigenetics Program, Fox Chase Cancer Center-Temple Health, Philadelphia, USA
| | - Andrew Andrews
- Cancer Epigenetics Program, Fox Chase Cancer Center-Temple Health, Philadelphia, USA
| | - Meganathan Ramakodi
- Cancer Prevention and Control Program, Fox Chase Cancer Center-Temple Health, Philadelphia, USA
- African-Caribbean Cancer Consortium, Philadelphia, USA
- Department of Biology, Temple University, Philadelphia, USA
| | - Karthik Devarajan
- Biostatistics and Bioinformatics Facility, Fox Chase Cancer Center, Philadelphia, USA
| | - Jackie Bucci
- Nutrition Program, City University of New York at Hunter College, New York, USA
- Temple University and Hunter College Cancer Health Disparity Research Institute Cancer Research Training Program, Fox Chase Cancer Center, Philadelphia, USA
| | | | | | - Barbara Wilson
- Caribbean Festival & Cultural Organization of Pennsylvania, Philadelphia, USA
| | - Carlene Bowen
- Thomas Jefferson University Hospital, Philadelphia, USA
| | - Eric Edi
- The Coalition of African Communities (AFRICOM), Philadelphia, USA
| | - Vera Tolbert
- The Coalition of African Communities (AFRICOM), Philadelphia, USA
| | | | - Daramola N. Cabral
- African-Caribbean Cancer Consortium, Philadelphia, USA
- Department of Science, Math, and Technology, SUNY Empire State College, Brooklyn, USA
| | - JoAnn Oliver
- African-Caribbean Cancer Consortium, Philadelphia, USA
- Capstone College of Nursing, Tuscaloosa, USA
| | - Robin Roberts
- African-Caribbean Cancer Consortium, Philadelphia, USA
- School of Clinical Medicine & Research, University of the West Indies, Nassau, Bahamas
- Princess Margaret Hospital, Nassau, Bahamas
| | - Marshall Tulloch-Reid
- African-Caribbean Cancer Consortium, Philadelphia, USA
- Caribbean Institute for Health Research, University of the West Indies, Kingston, Jamaica
| | - Camille Ragin
- Cancer Prevention and Control Program, Fox Chase Cancer Center-Temple Health, Philadelphia, USA
- Department of Epidemiology and Biostatistics, College of Public Health, Temple University, Philadelphia, USA
- African-Caribbean Cancer Consortium, Philadelphia, USA
- Nutrition Program, City University of New York at Hunter College, New York, USA
- Department of Otolaryngology-Head and Neck Surgery, Lewis Katz School of Medicine, Temple University School of Medicine, Philadelphia, USA
| |
Collapse
|
3
|
Kaninjing E, Francis D, Brignole K, Adeniji K, Aiken W, Dial C, Faruk M, Fatiregun O, Gachii A, Gibbs D, Gueye S, Jackson M, Jalloh M, Jibrin P, Karanam B, Shravana JK, Ndoye M, Ndukwe OC, Obafunwa J, Odedina F, Popoola A, Ragin C, White J, Yates C, Martin DN. Abstract PO-135: Utility of formalin-fixed, paraffin embedded prostate biospecimens from low-resource international settings for use in next generation sequencing studies in African-descent populations. Cancer Epidemiol Biomarkers Prev 2020. [DOI: 10.1158/1538-7755.disp20-po-135] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Abstract
Background: Men of African ancestry experience higher burden from prostate cancer compared to men of other ancestral backgrounds. Limitations in the availability of high-quality biospecimens have hindered the inclusion of this population in genetic studies of prostate cancer. The use of formalin-fixed paraffin-embedded (FFPE) tissues represents a potential rich source of genetic material particularly in some international settings, where fresh frozen tissue is difficult to obtain. Methods: A total of 976 FFPE blocks were collected between 2002 and 2017 from six international sites in Africa and the Caribbean. Genomic DNA was checked for quality and quantity. Differences in mean quality control (QC) for pre and post pathology training were assessed using t-test. Pearson chi-square with trend analysis examined association between time-category and QC success status. Association of continuous DNA quality (Q129/Q41 ratio) and time of specimen collection was estimated with linear regression. Samples with a DNA quantity >0.2µg and a Q129/Q41 ratio >0.00225 were submitted for whole exome sequencing (WES). Findings: Specimens from 2002 to 2010 and 2011 to 2017 had an average total DNA yield of 1.4 μg and 2.4 ug, respectively. There was a statistical positive difference in the quality of DNA samples over time indicating an improvement in quality of specimens. For the samples Insert size, mean mapping quality and alignment error rate significantly (p≤0.05) improved for samples submitted for WES, post pathology training. Interpretation: FFPE samples from low-resource settings could potentially provide sufficient DNA for WES. Improvements in biospecimen collection for research are needed in these settings.
Citation Format: Ernest Kaninjing, Damian Francis, Katy Brignole, Keyode Adeniji, William Aiken, Cherif Dial, Mohammed Faruk, Omolara Fatiregun, Andrew Gachii, Denise Gibbs, Serigne Gueye, Maria Jackson, Mohamed Jalloh, Paul Jibrin, B. Karanam, Jyoti Kumar Shravana, Mamadou Ndoye, Ogo Chidiebere Ndukwe, John Obafunwa, Folakemi Odedina, Ademola Popoola, Camile Ragin, Jason White, Clayton Yates, Damali N. Martin. Utility of formalin-fixed, paraffin embedded prostate biospecimens from low-resource international settings for use in next generation sequencing studies in African-descent populations [abstract]. In: Proceedings of the AACR Virtual Conference: Thirteenth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2020 Oct 2-4. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2020;29(12 Suppl):Abstract nr PO-135.
Collapse
Affiliation(s)
| | | | | | - Keyode Adeniji
- 3University of Ilorin Teaching Hospital, Ilorin, Kwara, Nigeria,
| | - William Aiken
- 4University of the West Indies, Mona, Kingston, Jamaica,
| | - Cherif Dial
- 5Hopital General Idrissa Pouye and University Cheikh Anta Diop, Dakar, Senegal,
| | | | | | | | | | - Serigne Gueye
- 5Hopital General Idrissa Pouye and University Cheikh Anta Diop, Dakar, Senegal,
| | - Maria Jackson
- 4University of the West Indies, Mona, Kingston, Jamaica,
| | - Mohamed Jalloh
- 5Hopital General Idrissa Pouye and University Cheikh Anta Diop, Dakar, Senegal,
| | | | | | - Jyoti Kumar Shravana
- 12Health Services Authority Hospital, George Town, Grand Cayman, Cayman Islands,
| | - Mamadou Ndoye
- 5Hopital General Idrissa Pouye and University Cheikh Anta Diop, Dakar, Senegal,
| | | | | | | | - Ademola Popoola
- 3University of Ilorin Teaching Hospital, Ilorin, Kwara, Nigeria,
| | | | | | | | - Damali N. Martin
- 16Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD
| |
Collapse
|
4
|
Dubey B, Jackson M, Zeigler-Johnson C, Devarajan K, Flores-Obando RE, McFarlane-Anderson N, Tulloch-Reid M, Aiken W, Kimbro K, Jones D, Kidd LR, Gibbs D, Kumar S, Ragin C. Interactive effect of TLR SNPs and exposure to sexually transmitted infections on prostate cancer risk in Jamaican men. Prostate 2020; 80:1365-1372. [PMID: 32894795 PMCID: PMC7710572 DOI: 10.1002/pros.24067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/02/2020] [Revised: 08/24/2020] [Accepted: 08/24/2020] [Indexed: 11/10/2022]
Abstract
BACKGROUND Prostate cancer (PC) risk increases with African ancestry and a history of sexually transmitted infections (STIs). Also, single-nucleotide polymorphisms (SNPs) in toll-like receptor (TLR) genes influence PC risk. This pilot study explores interactions between STIs and TLR-related SNPs in relation to PC risk among Jamaican men. METHODS This case-control study evaluates two TLR related SNPs in 356 Jamaican men (194 controls and 162 cases) with or without history of STIs using stepwise penalized logistic regression in multivariable analyses. RESULTS Age (odds ratio [OR] = 1.08; 95% confidence interval [CI]: 1.04-1>.12; p < .001) and IRF3_rs2304206 GG genotype (OR = 0.47; 95% CI: 0.29-0<.78; p = .003) modulated PC risk in people with history of STIs. In the population with no history of STIs, resulting interactions between risk factors did not survive correction for multiple hypothesis testing. CONCLUSION Overall, an interaction between the IFR3_rs2304206 variant and a history of exposure to STIs leads to greater decrease of PC risk than the presence of polymorphic genotype alone. These findings are suggestive and require further validation. Identification of gene variants along with detection of lifestyle behaviors may contribute to identification of men at a greater risk of PC development in the population.
Collapse
Affiliation(s)
- Bhawna Dubey
- Cancer Prevention and Control Program, Fox Chase Cancer Center, PA, USA
| | - Maria Jackson
- Department of Community Health and Psychiatry, University of West Indies, Mona Campus, Kingston, Jamaica
| | - Charnita Zeigler-Johnson
- Division of Population Sciences, Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA
| | - Karthik Devarajan
- Biostatistics and Bioinformatics, Fox Chase Cancer Center, Philadelphia, PA, USA
| | | | - Norma McFarlane-Anderson
- Department of Basic Medical Sciences, University of the West Indies, Mona Campus, Kingston, Jamaica
| | - Marshall Tulloch-Reid
- Caribbean Institute for Health Research, University of the West Indies, Mona, Kingston, Jamaica
| | - William Aiken
- Department of Surgery, Radiology, Anaesthesia and Intensive Care, Section of Surgery, Faculty of Medical Sciences, University of the West Indies, Mona Campus, Kingston, Jamaica
| | - Kevin Kimbro
- Biomedical/Biotechnology Research Institute, North Carolina Central University, Durham, NC, USA
| | - Dominique Jones
- Department of Pharmacology & Toxicology, University of Louisville, Louisville, KY, USA
| | - LaCreis R. Kidd
- Department of Pharmacology & Toxicology, University of Louisville, Louisville, KY, USA
| | - Denise Gibbs
- Cancer Prevention and Control Program, Fox Chase Cancer Center, PA, USA
| | - Sudhir Kumar
- Institute for Genomics and Evolutionary Medicine, Temple University, Philadelphia, PA, USA
| | - Camille Ragin
- Cancer Prevention and Control Program, Fox Chase Cancer Center, PA, USA
- To whom correspondence should be addressed: Cancer Prevention and Control Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, , Phone: 215-728-1148, FAX: 215-214-1622
| |
Collapse
|
5
|
Gibbs D, Blackman E, Kuo YM, Andrews A, Devarajan K, Ragin C. Abstract A012: Comparison of NNAL exposure and menthol cigarette use among Black smokers. Cancer Epidemiol Biomarkers Prev 2020. [DOI: 10.1158/1538-7755.disp19-a012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Abstract
Introduction: In the U.S., there is little information available on gender differences in menthol cigarette smoking use among Black smokers. NNAL, has been studied as a carcinogenic biomarker of tobacco and second-hand smoker exposure. Total NNAL was analyzed to compare gender differences in NNAL exposure and menthol cigarette use among Black smokers. Method: Urine samples were collected from 117 current smokers who self-reported as persons of African descent and participated in the Cancer Prevention Project of Philadelphia. Participants completed overall health and wellness questionnaires that included information on tobacco use. Samples were analyzed for NNAL using an ultra-performance liquid chromatography with tandem mass spectrometry along with urinary creatinine for NNAL normalization and urine flow correction. We compared mean NNAL concentrations and tobacco metabolism phenotype and menthol cigarette use by gender. Results: Our preliminary results are reported for 48 current smokers, 20 males and 28 females. The majority were daily smokers (males, 80%, females 68%). The majority of participants reported using mentholated cigarettes (total 63%, males 76.9% vs. females 54.6%, p=0.508). Tobacco exposure based on mean NNAL concentrations was higher but not significantly different between males (268 pg/mg creatinine ± 498 SD) and females (159 pg/mg creatinine ± 121 SD; p=0.645, Wilcoxon rank-sum test). Similarly tobacco exposure based on number of cigarettes per day was not (males 7.2 ± 6.6 cig/day vs. females 10.5 ± 7.8 cig/day, p= 0.139 Wilcoxon rank-sum test). Of those who reported use of filtered or mentholated cigarettes there was no significant difference according to sex (p>0.05). Mean NNAL was higher in Black men who smoked mentholated cigarettes compared to Black women but did not reach statistical significance (p = 0.598, Wilcoxon rank-sum test). The majority of smokers were poor metabolizers of tobacco (total 60%, males 60%, females 61%, p=0.261). For those who reported use of mentholated cigarettes there was no significant difference in metabolizer phenotype between males and females (p=0.655). Conclusion: As expected Blacks more often report using mentholated cigarettes and there was no significant difference between males and females for tobacco exposure and metabolism. Our analyses are ongoing as we investigate these findings to address gender differences and health disparities among smokers of African descent in a larger study sample.
Citation Format: Denise Gibbs, Elizabeth Blackman, Yin-Ming Kuo, Andrew Andrews, Karthik Devarajan, Camille Ragin. Comparison of NNAL exposure and menthol cigarette use among Black smokers [abstract]. In: Proceedings of the Twelfth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2019 Sep 20-23; San Francisco, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2020;29(6 Suppl_2):Abstract nr A012.
Collapse
Affiliation(s)
- Denise Gibbs
- 1Cancer Prevention and Control Program, Fox Chase Cancer Center-Temple Health, African-Caribbean Cancer Consortium, Philadelphia, PA, USA,
| | - Elizabeth Blackman
- 2Cancer Prevention and Control Program, Fox Chase Cancer Center-Temple Health, Department of Epidemiology and Biostatistics, College of Public Health, Temple University, African-Caribbean Cancer Consortium, Philadelphia, PA, USA,
| | - Yin-Ming Kuo
- 3Department of Radiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA,
| | - Andrew Andrews
- 4Cancer Prevention and Control Program, Fox Chase Cancer Center-Temple Health, Philadelphia, PA, USA
| | - Karthik Devarajan
- 4Cancer Prevention and Control Program, Fox Chase Cancer Center-Temple Health, Philadelphia, PA, USA
| | - Camille Ragin
- 2Cancer Prevention and Control Program, Fox Chase Cancer Center-Temple Health, Department of Epidemiology and Biostatistics, College of Public Health, Temple University, African-Caribbean Cancer Consortium, Philadelphia, PA, USA,
| |
Collapse
|
6
|
Harniess P, Gibbs D, Basu A, Bezemer J. Optimising parental engagement in early intervention physical therapy for infants with cerebral palsy - a realist synthesis. Physiotherapy 2020. [DOI: 10.1016/j.physio.2020.03.093] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
7
|
Boshoff K, Gibbs D, Phillips RL, Wiles L, Porter L. Parents' voices: "Our process of advocating for our child with autism." A meta-synthesis of parents' perspectives. Child Care Health Dev 2018; 44:147-160. [PMID: 28833334 DOI: 10.1111/cch.12504] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/01/2016] [Revised: 07/20/2017] [Accepted: 07/22/2017] [Indexed: 11/27/2022]
Abstract
BACKGROUND Advocacy has been described by parents of children with autism as an important coping strategy, enabling them to move forward by redirecting emotions into actions. A key factor in the development of collaborative and constructive partnerships between service providers and parents is having an understanding of how parents engage in advocacy and the support needed to do so. This meta-synthesis was undertaken to consolidate in-depth qualitative data from parents' perspectives of the process that they use to advocate for their children with autism. METHODS A qualitative meta-synthesis was conducted, whereby 15 databases were systematically searched. Thirty-one studies were identified and appraised using an adapted version of the Critical Appraisal Skills Programme tool. Data were synthesized into themes through the steps of review, meta-aggregation, integration, and interpretation. RESULTS The voices of 1,662 parents are presented describing the process of advocacy in the stages of seeking a diagnosis, seeking self-education, and taking action. Taking action includes 2 subthemes: seeking, access, and use of support services and community engagement and educating others. CONCLUSIONS Results highlight the significant impact that positive experiences with first-line professionals have during the diagnosis process and how these experiences lay the foundation for all future relationships with other service providers. Important implications arise from this meta-synthesis for service providers in supporting parents' advocacy and hence building constructive relationships with families with a child with autism.
Collapse
Affiliation(s)
- K Boshoff
- International Centre for Allied Health Evidence, School of Health Sciences, University of South Australia, Adelaide, South Australia
| | - D Gibbs
- Barts Health NHS Trust, Royal London Hospital, London, UK
| | - R L Phillips
- Centre for Health Stewardship, The Australian National University, Canberra, Australia
| | - L Wiles
- International Centre for Allied Health Evidence, School of Health Sciences, University of South Australia, Adelaide, South Australia
| | - L Porter
- International Centre for Allied Health Evidence, School of Health Sciences, University of South Australia, Adelaide, South Australia
| |
Collapse
|
8
|
Stacey WM, Van Rooijen W, Bates T, Colvin E, Dion J, Feener J, Gayton E, Gibbs D, Grennor C, Head J, Hope F, Ireland J, Johnson A, Jones B, Mejias N, Myers C, Schmitz A, Sommer C, Sumner T, Tschaepe L. A TRU-Zr Metal-Fuel Sodium-Cooled Fast Subcritical Advanced Burner Reactor. NUCL TECHNOL 2017. [DOI: 10.13182/nt08-a3933] [Citation(s) in RCA: 36] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- W. M. Stacey
- Georgia Institute of Technology Nuclear and Radiological Engineering Program, Atlanta, Georgia 30332-0425
| | - W. Van Rooijen
- Georgia Institute of Technology Nuclear and Radiological Engineering Program, Atlanta, Georgia 30332-0425
| | - T. Bates
- Georgia Institute of Technology Nuclear and Radiological Engineering Program, Atlanta, Georgia 30332-0425
| | - E. Colvin
- Georgia Institute of Technology Nuclear and Radiological Engineering Program, Atlanta, Georgia 30332-0425
| | - J. Dion
- Georgia Institute of Technology Nuclear and Radiological Engineering Program, Atlanta, Georgia 30332-0425
| | - J. Feener
- Georgia Institute of Technology Nuclear and Radiological Engineering Program, Atlanta, Georgia 30332-0425
| | - E. Gayton
- Georgia Institute of Technology Nuclear and Radiological Engineering Program, Atlanta, Georgia 30332-0425
| | - D. Gibbs
- Georgia Institute of Technology Nuclear and Radiological Engineering Program, Atlanta, Georgia 30332-0425
| | - C. Grennor
- Georgia Institute of Technology Nuclear and Radiological Engineering Program, Atlanta, Georgia 30332-0425
| | - J. Head
- Georgia Institute of Technology Nuclear and Radiological Engineering Program, Atlanta, Georgia 30332-0425
| | - F. Hope
- Georgia Institute of Technology Nuclear and Radiological Engineering Program, Atlanta, Georgia 30332-0425
| | - J. Ireland
- Georgia Institute of Technology Nuclear and Radiological Engineering Program, Atlanta, Georgia 30332-0425
| | - A. Johnson
- Georgia Institute of Technology Nuclear and Radiological Engineering Program, Atlanta, Georgia 30332-0425
| | - B. Jones
- Georgia Institute of Technology Nuclear and Radiological Engineering Program, Atlanta, Georgia 30332-0425
| | - N. Mejias
- Georgia Institute of Technology Nuclear and Radiological Engineering Program, Atlanta, Georgia 30332-0425
| | - C. Myers
- Georgia Institute of Technology Nuclear and Radiological Engineering Program, Atlanta, Georgia 30332-0425
| | - A. Schmitz
- Georgia Institute of Technology Nuclear and Radiological Engineering Program, Atlanta, Georgia 30332-0425
| | - C. Sommer
- Georgia Institute of Technology Nuclear and Radiological Engineering Program, Atlanta, Georgia 30332-0425
| | - T. Sumner
- Georgia Institute of Technology Nuclear and Radiological Engineering Program, Atlanta, Georgia 30332-0425
| | - L. Tschaepe
- Georgia Institute of Technology Nuclear and Radiological Engineering Program, Atlanta, Georgia 30332-0425
| |
Collapse
|
9
|
Williams DS, Chadha A, Hazim R, Gibbs D. Gene therapy approaches for prevention of retinal degeneration in Usher syndrome. Gene Ther 2017; 24:68-71. [PMID: 28054582 DOI: 10.1038/gt.2016.81] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2016] [Revised: 11/11/2016] [Accepted: 11/17/2016] [Indexed: 01/04/2023]
Affiliation(s)
- D S Williams
- Stein Eye Institute, UCLA School of Medicine, Los Angeles, CA, USA.,Departments of Ophthalmology and Neurobiology, UCLA School of Medicine, Los Angeles, CA, USA
| | - A Chadha
- Stein Eye Institute, UCLA School of Medicine, Los Angeles, CA, USA.,Departments of Ophthalmology and Neurobiology, UCLA School of Medicine, Los Angeles, CA, USA
| | - R Hazim
- Stein Eye Institute, UCLA School of Medicine, Los Angeles, CA, USA.,Departments of Ophthalmology and Neurobiology, UCLA School of Medicine, Los Angeles, CA, USA.,Interdepartmental Program in Neurosciences, UCLA School of Medicine, Los Angeles, CA, USA
| | - D Gibbs
- Translational Neurosciences Institute, Department of Neurosciences, UCSD School of Medicine, La Jolla, CA, USA
| |
Collapse
|
10
|
Ragin C, Liu JC, Jones G, Shoyele O, Sowunmi B, Kennett R, Groen HJM, Gibbs D, Blackman E, Esan M, Brandwein MS, Devarajan K, Bussu F, Chernock R, Chien CY, Cohen MA, Samir EM, Mikio S, D'Souza G, Funchain P, Eng C, Gollin SM, Hong A, Jung YS, Krüger M, Lewis J, Morbini P, Landolfo S, Rittà M, Straetmans J, Szarka K, Tachezy R, Worden FP, Nelson D, Gathere S, Taioli E. Prevalence of HPV Infection in Racial-Ethnic Subgroups of Head and Neck Cancer Patients. Carcinogenesis 2016; 38:218-229. [PMID: 28025390 DOI: 10.1093/carcin/bgw203] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2016] [Indexed: 12/13/2022] Open
Abstract
The landscape of HPV infection in racial/ethnic subgroups of head and neck cancer (HNC) patients has not been evaluated carefully. In this study, a meta-analysis examined the prevalence of HPV in HNC patients of African ancestry. Additionally, a pooled analysis of subject-level data was also performed to investigate HPV prevalence and patterns of p16 (CDNK2A) expression amongst different racial groups. Eighteen publications (N = 798 Black HNC patients) were examined in the meta-analysis, and the pooled analysis included 29 datasets comprised of 3,129 HNC patients of diverse racial/ethnic background. The meta-analysis revealed that the prevalence of HPV16 was higher among Blacks with oropharyngeal cancer than Blacks with non-oropharyngeal cancer. However, there was great heterogeneity observed among studies (Q test P<0.0001). In the pooled analysis, after adjusting for each study, year of diagnosis, age, gender and smoking status, the prevalence of HPV16/18 in oropharyngeal cancer patients was highest in Whites (61.1%), followed by 58.0% in Blacks and 25.2% in Asians (P<0.0001). There was no statistically significant difference in HPV16/18 prevalence in non-oropharyngeal cancer by race (P=0.682). With regard to the pattern of HPV16/18 status and p16 expression, White patients had the highest proportion of HPV16/18+/p16+ oropharyngeal cancer (52.3%), while Asians and Blacks had significantly lower proportions (23.0% and 22.6%, respectively) [P <0.0001]. Our findings suggest that the pattern of HPV16/18 status and p16 expression in oropharyngeal cancer appears to differ by race and this may contribute to survival disparities.
Collapse
Affiliation(s)
- Camille Ragin
- Cancer Prevention and Control Program, Fox Chase Cancer Center - Temple Health, Philadelphia, PA, USA
- Department of Epidemiology & Biostatistics, Temple University, College of Public Health, Philadelphia, PA, USA
| | - Jeffrey C Liu
- Department of Otolaryngology, Temple University; and Fox Chase Cancer Center, Philadelphia, PA, USA
| | - Gieira Jones
- Department of Epidemiology & Biostatistics, Temple University, College of Public Health, Philadelphia, PA, USA
| | - Olubunmi Shoyele
- Department of Pathology and Laboratory Medicine, Western Connecticut Health Network, Danbury Hospital, Danbury, CT, USA
| | - Bukola Sowunmi
- Cancer Prevention and Control Program, Fox Chase Cancer Center - Temple Health, Philadelphia, PA, USA
| | - Rachel Kennett
- Cancer Prevention and Control Program, Fox Chase Cancer Center - Temple Health, Philadelphia, PA, USA
| | - Harry J M Groen
- Department of Epidemiology & Biostatistics, Temple University, College of Public Health, Philadelphia, PA, USA
| | - Denise Gibbs
- Cancer Prevention and Control Program, Fox Chase Cancer Center - Temple Health, Philadelphia, PA, USA
| | - Elizabeth Blackman
- Cancer Prevention and Control Program, Fox Chase Cancer Center - Temple Health, Philadelphia, PA, USA
- Department of Epidemiology & Biostatistics, Temple University, College of Public Health, Philadelphia, PA, USA
| | - Michael Esan
- Cancer Prevention and Control Program, Fox Chase Cancer Center - Temple Health, Philadelphia, PA, USA
| | - Margaret S Brandwein
- Department of Pathology and Anatomical Sciences, SUNY at the University at Buffalo, Buffalo, NY, USA
| | - Karthik Devarajan
- Department of Biostatistics, Fox Chase Cancer Center - Temple Health, Philadelphia, PA, USA
| | - Francesco Bussu
- Institute of Otolaryngology, Università Cattolica del Sacro Cuore, Policlinico Agostino Gemelli, Rome, Italy
| | - Rebecca Chernock
- Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA
| | - Chih-Yen Chien
- Department of Otolaryngology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan
| | - Marc A Cohen
- Department of Surgery, Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - El-Mofty Samir
- Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA
| | - Suzuki Mikio
- Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan
| | - Gypsyamber D'Souza
- Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
| | - Pauline Funchain
- Genomic Medicine Institute, Cleveland Clinic Lerner Research Institute, Cleveland, OH, USA
| | - Charis Eng
- Genomic Medicine Institute, Cleveland Clinic Lerner Research Institute, Cleveland, OH, USA
| | - Susanne M Gollin
- Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA USA
| | - Angela Hong
- Central Clinical School, The University of Sydney, Sydney, NSW, Australia
| | - Yuh-S Jung
- Department of Otolaryngology, Research Institute and Hospital, National Cancer Center, Gyeonggi-do, Korea
| | - Maximilian Krüger
- Department of Oral and Maxillofacial Surgery - Plastic Surgery, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany
| | - James Lewis
- Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, TN, 37232, USA
| | - Patrizia Morbini
- Department of Molecular Medicine, Unit of Pathology, University of Pavia, and à IRCCS Policlinico S. Matteo Foundation, Pavia, Italy
| | - Santo Landolfo
- Department of Sciences of Public Health and Pediatrics, University of Turin, Turin, Italy
| | - Massimo Rittà
- Department of Sciences of Public Health and Pediatrics, University of Turin, Turin, Italy
| | - Jos Straetmans
- Department of Otorhinolaryngology-Head and Neck Surgery, GROW Institute, Maastricht University Medical Centre, Maastricht, The Netherlands
| | - Krisztina Szarka
- Department of Medical Microbiology, Faculty of Medicine, University of Debrecen, Hungary
| | - Ruth Tachezy
- Department of Immunology, Institute of Hematology and Blood Transfusion National Reference Laboratory for Papillomaviruses, Prague, Czech Republic
| | - Francis P Worden
- Department of Internal Medicine, Division of Hematology-Oncology, University of Michigan, Ann Arbor, MI, USA
| | - Deborah Nelson
- Department of Epidemiology & Biostatistics, Temple University, College of Public Health, Philadelphia, PA, USA
| | - Samuel Gathere
- Non Communicable Diseases Research Programme, Kenya Medical Research Institute, Nairobi, Kenya
| | - Emanuela Taioli
- Departments of Population Health Science and Policy, of Thoracic Surgery, and Institute For Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| |
Collapse
|
11
|
Ramakodi MP, Devarajan K, Blackman E, Gibbs D, Luce D, Deloumeaux J, Duflo S, Liu JC, Mehra R, Kulathinal RJ, Ragin CC. Integrative genomic analysis identifies ancestry-related expression quantitative trait loci on DNA polymerase β and supports the association of genetic ancestry with survival disparities in head and neck squamous cell carcinoma. Cancer 2016; 123:849-860. [PMID: 27906459 DOI: 10.1002/cncr.30457] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2016] [Revised: 09/26/2016] [Accepted: 10/28/2016] [Indexed: 12/25/2022]
Abstract
BACKGROUND African Americans with head and neck squamous cell carcinoma (HNSCC) have a lower survival rate than whites. This study investigated the functional importance of ancestry-informative single-nucleotide polymorphisms (SNPs) in HNSCC and also examined the effect of functionally important genetic elements on racial disparities in HNSCC survival. METHODS Ancestry-informative SNPs, RNA sequencing, methylation, and copy number variation data for 316 oral cavity and laryngeal cancer patients were analyzed across 178 DNA repair genes. The results of expression quantitative trait locus (eQTL) analyses were also replicated with a Gene Expression Omnibus (GEO) data set. The effects of eQTLs on overall survival (OS) and disease-free survival (DFS) were evaluated. RESULTS Five ancestry-related SNPs were identified as cis-eQTLs in the DNA polymerase β (POLB) gene (false discovery rate [FDR] < 0.01). The homozygous/heterozygous genotypes containing the African allele showed higher POLB expression than the homozygous white allele genotype (P < .001). A replication study using a GEO data set validated all 5 eQTLs and also showed a statistically significant difference in POLB expression based on genetic ancestry (P = .002). An association was observed between these eQTLs and OS (P < .037; FDR < 0.0363) as well as DFS (P = .018 to .0629; FDR < 0.079) for oral cavity and laryngeal cancer patients treated with platinum-based chemotherapy and/or radiotherapy. Genotypes containing the African allele were associated with poor OS/DFS in comparison with homozygous genotypes harboring the white allele. CONCLUSIONS Analyses show that ancestry-related alleles could act as eQTLs in HNSCC and support the association of ancestry-related genetic factors with survival disparities in patients diagnosed with oral cavity and laryngeal cancer. Cancer 2017;123:849-60. © 2016 American Cancer Society.
Collapse
Affiliation(s)
- Meganathan P Ramakodi
- Cancer Prevention and Control Program, Fox Chase Cancer Center-Temple Health, Philadelphia, Pennsylvania.,Department of Biology, Temple University, Philadelphia, Pennsylvania.,Center for Computational Genetics and Genomics, Temple University, Philadelphia, Pennsylvania.,Institute for Genomics and Evolutionary Medicine, Temple University, Philadelphia, Pennsylvania.,African-Caribbean Cancer Consortium, Philadelphia, Pennsylvania
| | - Karthik Devarajan
- Biostatistics and Bioinformatics Facility, Fox Chase Cancer Center-Temple Health, Philadelphia, Pennsylvania.,Department of Epidemiology and Biostatistics, College of Public Health, Temple University, Philadelphia, Pennsylvania.,Center for High-Dimensional Statistics, Big Data Institute, Temple University, Philadelphia, Pennsylvania
| | - Elizabeth Blackman
- Cancer Prevention and Control Program, Fox Chase Cancer Center-Temple Health, Philadelphia, Pennsylvania.,African-Caribbean Cancer Consortium, Philadelphia, Pennsylvania
| | - Denise Gibbs
- Cancer Prevention and Control Program, Fox Chase Cancer Center-Temple Health, Philadelphia, Pennsylvania.,African-Caribbean Cancer Consortium, Philadelphia, Pennsylvania
| | - Danièle Luce
- African-Caribbean Cancer Consortium, Philadelphia, Pennsylvania.,National Institute for Health and Medical Research (INSERM), Unit 1085;, Institute for Research in Health, Environment, and Work (IRSET), Pointe-à-Pitre, Guadeloupe, French West Indies
| | - Jacqueline Deloumeaux
- African-Caribbean Cancer Consortium, Philadelphia, Pennsylvania.,General Cancer Registry of Guadeloupe, University Hospital of Pointe-à-Pitre, Pointe-a-Pitre, Guadeloupe, French West Indies
| | - Suzy Duflo
- Department of Oto-Rhino-Laryngology and Head and Neck Surgery, University Hospital of Pointe à Pitre, Pointe-a-Pitre, Guadeloupe, French West Indies
| | - Jeffrey C Liu
- Head and Neck Surgery, Fox Chase Cancer Center-Temple Health, Philadelphia, Pennsylvania.,Department of Otolaryngology-Head and Neck Surgery, Lewis Katz School of Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania
| | - Ranee Mehra
- Department of Hematology/Oncology, Fox Chase Cancer Center-Temple Health, Philadelphia, Pennsylvania
| | - Rob J Kulathinal
- Department of Biology, Temple University, Philadelphia, Pennsylvania.,Center for Computational Genetics and Genomics, Temple University, Philadelphia, Pennsylvania.,Institute for Genomics and Evolutionary Medicine, Temple University, Philadelphia, Pennsylvania.,African-Caribbean Cancer Consortium, Philadelphia, Pennsylvania
| | - Camille C Ragin
- Cancer Prevention and Control Program, Fox Chase Cancer Center-Temple Health, Philadelphia, Pennsylvania.,African-Caribbean Cancer Consortium, Philadelphia, Pennsylvania.,Department of Epidemiology and Biostatistics, College of Public Health, Temple University, Philadelphia, Pennsylvania.,Department of Otolaryngology-Head and Neck Surgery, Lewis Katz School of Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania
| |
Collapse
|
12
|
Boshoff K, Gibbs D, Phillips RL, Wiles L, Porter L. Parents' voices: 'why and how we advocate'. A meta-synthesis of parents' experiences of advocating for their child with autism spectrum disorder. Child Care Health Dev 2016; 42:784-797. [PMID: 27445227 DOI: 10.1111/cch.12383] [Citation(s) in RCA: 39] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/24/2015] [Revised: 06/16/2016] [Accepted: 06/25/2016] [Indexed: 01/24/2023]
Abstract
Parenting a child with autism spectrum disorder (ASD) can be stressful, and accessing services can add to this stress. Self-efficacy, agency and advocacy are important for parents when accessing and using services. To develop insight into parental advocacy, a meta-synthesis was undertaken to consolidate the literature focussing on parents' experiences of advocating for their child with ASD. A qualitative meta-synthesis was conducted. Fifteen databases were systematically searched by using key terms related to ASD, children, parents/carers, advocacy and qualitative studies. Twenty-four studies were identified and appraised using an adapted version of the Critical Appraisal Skills Programme tool. Data were synthesized into themes through the steps of review, meta-aggregation, integration and interpretation. Two overarching concepts emerged, illustrating both the challenging nature of advocacy and the associated personal and societal benefits. These two concepts are supported by eight themes: a life-long, all-encompassing challenge; advocacy as a parental coping strategy; advocacy involving working to create a future; balancing roles and needs; isolation versus support; personal impacts of advocacy; benefits of advocacy; and the barriers to advocacy. The experience of advocacy for parents with a child with ASD is complex and intensive, presenting both personal and societal benefits, as well as challenges for parents. In supporting individuals with ASD and family well-being, service providers need to have an understanding of the advocating role of parents and ensure that opportunities exist for their voices to be heard during service delivery.
Collapse
Affiliation(s)
- K Boshoff
- International Centre for Allied Health Evidence, School of Health Sciences, University of South Australia, Adelaide, SA, Australia.
| | - D Gibbs
- Royal London Hospital, Barts Health NHS Trust, London, UK
| | - R L Phillips
- Centre for Health Stewardship, The Australian National University, Canberra, NSW, Australia
| | - L Wiles
- International Centre for Allied Health Evidence, School of Health Sciences, University of South Australia, Adelaide, SA, Australia
| | - L Porter
- International Centre for Allied Health Evidence, School of Health Sciences, University of South Australia, Adelaide, SA, Australia
| |
Collapse
|
13
|
Liu JC, Parajuli S, Blackman E, Gibbs D, Ellis A, Hull A, Beck JR, Giri V, Iherjirka P, Khurana JS, Ragin CR. High prevalence of discordant human papillomavirus and p16 oropharyngeal squamous cell carcinomas in an African American cohort. Head Neck 2015; 38 Suppl 1:E867-72. [PMID: 25962720 DOI: 10.1002/hed.24117] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/05/2015] [Indexed: 01/25/2023] Open
Abstract
BACKGROUND Most studies on human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (SCC) have been performed on white Americans. Our study examined the incidence of HPV in an African American oropharyngeal SCC cohort and its survival. METHODS African American patients with oropharyngeal SCC in a combined tumor registry were identified. HPV16 testing was performed by polymerase chain reaction (PCR) from DNA extracted from tumor blocks. The p16 staining was performed using standard immunohistochemistry. RESULTS Forty-four patients were identified for analysis. Seventy-three percent of the tumors were HPV-positive. Only 39% of the patients who were HPV-positive were also p16-positive. Survival between all 3 tumor types, patients who tested HPV-positive/p16, HPV-positive/p16-positive, and HPV-negative/p16-negative was significantly different (p = .03). HPV/p16 status was significant on univariate and multivariate analysis. CONCLUSION HPV oropharyngeal SCC is strongly present in this African American cohort. Two thirds of the patients who were HPV-positive were p16-negative. Greater study is needed to explain the high p16 negativity among this HPV-positive oropharyngeal SCC African American cohort. © 2015 Wiley Periodicals, Inc. Head Neck 38: E867-E872, 2016.
Collapse
Affiliation(s)
- Jeffrey C Liu
- Department of Otolaryngology - Head and Neck Surgery, Temple University School of Medicine, Philadelphia, Pennsylvania.,Cancer Prevention and Control Program, Fox Chase Cancer Center, Temple Health, Philadelphia, Pennsylvania
| | - Shobha Parajuli
- Department of Pathology, Temple University School of Medicine, Philadelphia, Pennsylvania
| | - Elizabeth Blackman
- Cancer Prevention and Control Program, Fox Chase Cancer Center, Temple Health, Philadelphia, Pennsylvania
| | - Denise Gibbs
- Cancer Prevention and Control Program, Fox Chase Cancer Center, Temple Health, Philadelphia, Pennsylvania
| | - Ashley Ellis
- Department of Chemistry, The Lincoln University, Lincoln University, Philadelphia, Pennsylvania
| | - Anna Hull
- Department of Biology, The Lincoln University, Lincoln University, Philadelphia, Pennsylvania
| | - J Robert Beck
- Cancer Prevention and Control Program, Fox Chase Cancer Center, Temple Health, Philadelphia, Pennsylvania
| | - Veda Giri
- Division of Population Science, Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA
| | - Patrick Iherjirka
- Department of Chemistry, The Lincoln University, Lincoln University, Philadelphia, Pennsylvania
| | - Jasvir S Khurana
- Department of Pathology, Temple University School of Medicine, Philadelphia, Pennsylvania
| | - Camille R Ragin
- Cancer Prevention and Control Program, Fox Chase Cancer Center, Temple Health, Philadelphia, Pennsylvania
| |
Collapse
|
14
|
Ragin CR, Jones G, Shoyele O, Esan M, Gibbs D, Liu J, Gathere S, Taioli E. Abstract C92: Systematic review of the literature confirms disparities in the prevalence of HPV-positive oropharynx cancer between African Americans and U.S. whites. Cancer Epidemiol Biomarkers Prev 2014. [DOI: 10.1158/1538-7755.disp13-c92] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Abstract
Background: Head and neck cancer (HNC) includes cancers of the oral cavity, larynx and pharynx (which include the oropharynx) and is the sixth most common cancer in the world. Approximately 52,610 new cases and 11,500 deaths from HNC were expected in the United States in 2012. Tobacco and alcohol use are the primary risk factors for developing HNC and human papillomavirus (HPV) is etiologically linked to the majority of oropharynx cancers. HPV-positive oropharyngeal cancer patients have been shown to have improved survival rates compared to HPV-negative patients. It has been suggested that the noted disparity in oropharyngeal cancer survival between African-Americans and Caucasians is due to a lower prevalence of HPV-positive oropharynx tumors in African-American patients. To date this documentation has been limited to only a few small studies.
Purpose: In this study we have conducted a systematic review and meta-analysis of the literature to confirm whether a racial disparity in the prevalence of HPV-positive tumors exists between African Americans and US Whites.
Results: All articles conducted in the United States that report HPV prevalence by direct evaluation of HNC tissues were included in this study. Studies that evaluated p16 status or HPV serological status as a surrogate marker for HPV-positive HNC were not included. Ninety-four studies were identified which included data for 9,144 cases. There were 15 studies (278 cases) that reported HPV status of HNC from African American patients while 24 studies (2,853 cases) reported HPV status of HNC from White patients. For all other studies race-specific prevalence of HPV was indistinguishable. Preliminary analyses show that overall for African Americans the meta prevalence of HPV-positive HNC was 17.8%, (95% Confidence interval[CI], 13.4-23.3). No heterogeneity was observed between studies (Q-test p-value = 0.172, I-squared = 26%, 0-61). Stratification of these data according to oropharynx and non-oropharynx sub-sites did not result in significant differences (meta prevalence: oropharynx = 18.8%, 95% CI, 10.2-32.1; non-oropharynx = 17.8%, 95% CI, 10.6-28.3). There was also no evidence of heterogeneity between the studies and no evidence of publication bias was observed (Eggers-test p-value, 0.224). In contrast the meta prevalence of HPV-positive HNC in US Whites was 42.7%, 95% CI, 34.7-51.1 but there was large heterogeneity between the studies (Q-test p-value <0.0001, I-squared > 90%). Stratification of the studies between oropharynx and non-oropharynx sub-sites did not resolve the heterogeneity between the studies. There was also no evidence of publication bias (Eggers-test p-value, 0.993). Further investigations are ongoing.
Conclusions: Our preliminary findings show that disparity HPV-positive oropharyngeal cancers exist between African Americans and US Whites. The lower prevalence of HPV in African Americans diagnosed with oropharyngeal cancer may explain in part the poor outcomes observed in these populations. Further investigations of possible reasons for this disparity are needed.
Citation Format: Camille Ragin Ragin, Gieira Jones, Olubunmi Shoyele, Michael Esan, Denise Gibbs, Jeffery Liu, Samuel Gathere, Emanuela Taioli. Systematic review of the literature confirms disparities in the prevalence of HPV-positive oropharynx cancer between African Americans and U.S. whites. [abstract]. In: Proceedings of the Sixth AACR Conference: The Science of Cancer Health Disparities; Dec 6–9, 2013; Atlanta, GA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2014;23(11 Suppl):Abstract nr C92. doi:10.1158/1538-7755.DISP13-C92
Collapse
Affiliation(s)
| | | | | | | | | | | | | | - Emanuela Taioli
- 4The Feinstein Institute for Medical Research, Manhasset, NY
| |
Collapse
|
15
|
Langridge S, Watson GM, Gibbs D, Betouras JJ, Gidopoulos NI, Pollmann F, Long MW, Vettier C, Lander GH. Distinct magnetic phase transition at the surface of an antiferromagnet. Phys Rev Lett 2014; 112:167201. [PMID: 24815664 DOI: 10.1103/physrevlett.112.167201] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/10/2013] [Indexed: 06/03/2023]
Abstract
In the majority of magnetic systems the surface is required to order at the same temperature as the bulk. In the present Letter, we report a distinct and unexpected surface magnetic phase transition at a lower temperature than the Néel temperature. Employing grazing incidence x-ray resonant magnetic scattering, we have observed the near-surface behavior of uranium dioxide. UO2 is a noncollinear, triple-q, antiferromagnet with the U ions on a face-centered cubic lattice. Theoretical investigations establish that at the surface the energy increase-due to the lost bonds-is reduced when the spins near the surface rotate, gradually losing their component normal to the surface. At the surface the lowest-energy spin configuration has a double-q (planar) structure. With increasing temperature, thermal fluctuations saturate the in-plane crystal field anisotropy at the surface, leading to soft excitations that have ferromagnetic XY character and are decoupled from the bulk. The structure factor of a finite two-dimensional XY model fits the experimental data well for several orders of magnitude of the scattered intensity. Our results support a distinct magnetic transition at the surface in the Kosterlitz-Thouless universality class.
Collapse
Affiliation(s)
- S Langridge
- ISIS Facility, STFC Rutherford Appleton Laboratory, Harwell Science and Innovation Campus, Oxon OX11 0QX, United Kingdom
| | - G M Watson
- Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - D Gibbs
- Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - J J Betouras
- Department of Physics, University of Loughborough, Loughborough LE11 3TU, United Kingdom
| | - N I Gidopoulos
- Department of Physics, Durham University, South Road, Durham DH1 3LE, United Kingdom
| | - F Pollmann
- Max Planck Institute for Physics of Complex Systems, Noethnitzer Strasse 38, 01187 Dresden, Germany
| | - M W Long
- School of Physics, Birmingham University, Edgbaston, Birmingham B15 2TT, United Kingdom
| | - C Vettier
- European Synchrotron Radiation Facility, BP 220, F-38043 Grenoble Cedex, France
| | - G H Lander
- European Commission, Joint Research Center, Institute for Transuranium Elements, Postfach 2340, D-76125 Karlsruhe, Germany
| |
Collapse
|
16
|
Ragin C, Obikoya-Malomo M, Kim S, Chen Z, Flores-Obando R, Gibbs D, Koriyama C, Aguayo F, Koshiol J, Caporaso NE, Carpagnano GE, Ciotti M, Dosaka-Akita H, Fukayama M, Goto A, Spandidos DA, Gorgoulis V, Heideman DAM, van Boerdonk RAA, Hiroshima K, Iwakawa R, Kastrinakis NG, Kinoshita I, Akiba S, Landi MT, Eugene Liu H, Wang JL, Mehra R, Khuri FR, Lim WT, Owonikoko TK, Ramalingam S, Sarchianaki E, Syrjanen K, Tsao MS, Sykes J, Hee SW, Yokota J, Zaravinos A, Taioli E. HPV-associated lung cancers: an international pooled analysis. Carcinogenesis 2014; 35:1267-75. [PMID: 24523449 DOI: 10.1093/carcin/bgu038] [Citation(s) in RCA: 50] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
Abstract
Human papillomavirus (HPV) is the etiologic risk factor for cervical cancer. Some studies have suggested an association with a subset of lung tumors, but the etiologic link has not been firmly established. We performed an international pooled analysis of cross-sectional studies (27 datasets, n = 3249 patients) to evaluate HPV DNA prevalence in lung cancer and to investigate viral presence according to clinical and demographic characteristics. HPV16/18 were the most commonly detected, but with substantial variation in viral prevalence between geographic regions. The highest prevalence of HPV16/18 was observed in South and Central America, followed by Asia, North America and Europe (adjusted prevalence rates = 22, 5, 4 and 3%, respectively). Higher HPV16 prevalence was noted in each geographic region compared with HPV18, except in North America. HPV16/18-positive lung cancer was less likely observed among White race (adjusted odds ratio [OR] = 0.33, 95% confidence interval [CI] = 0.12-0.90), whereas no associations were observed with gender, smoking history, age, histology or stage. Comparisons between tumor and normal lung tissue show that HPV was more likely to be present in lung cancer rather than normal lung tissues (OR = 3.86, 95% CI = 2.87-5.19). Among a subset of patients with HPV16-positive tumors, integration was primarily among female patients (93%, 13/14), while the physical status in male cases (N = 14) was inconsistent. Our findings confirm that HPV DNA is present in a small fraction of lung tumors, with large geographic variations. Further comprehensive analysis is needed to assess whether this association reflects a causal relationship.
Collapse
Affiliation(s)
- Camille Ragin
- Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA, USA,
| | | | - Sungjin Kim
- Biostatistics & Bioinformatics, Winship Cancer Institute, Emory University, Atlanta, GA, USA
| | - Zhengjia Chen
- Biostatistics & Bioinformatics, Winship Cancer Institute, Emory University, Atlanta, GA, USA
| | - Rafael Flores-Obando
- Department of Cell Biology, State University of New York, Downstate Medical Center, Brooklyn, NY, USA
| | - Denise Gibbs
- Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA, USA
| | - Chihaya Koriyama
- Department of Epidemiology and Preventative Medicine, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima, Japan
| | - Francisco Aguayo
- Virology Program, Instituto de Ciencias Biomédicas (ICBM), Faculty of Medicine, University of Chile, Santiago, Chile
| | | | - Neil E Caporaso
- Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
| | - Giovanna E Carpagnano
- Department of Medical and Surgical Sciences, Faculty of Medicine, University of Foggia, Foggia, Italy
| | - Marco Ciotti
- Laboratory of Molecular Virology, Foundation Polyclinic Tor Vergata, Rome, Italy
| | - Hirotoshi Dosaka-Akita
- Department of Medical Oncology, Hokkaido University, Graduate School of Medicine, North 15, West 7, Kita-ku, Sapporo 060-8638, Japan
| | - Masashi Fukayama
- Department and Cellular and Organ Pathology, Graduate School of Medicine, Akita University, 1-1-1 Hondo, Akita 010-8543, Japan
| | - Akiteru Goto
- Department and Cellular and Organ Pathology, Graduate School of Medicine, Akita University, 1-1-1 Hondo, Akita 010-8543, Japan
| | - Demetrios A Spandidos
- Faculty of Medicine, Laboratory of Clinical Virology, 5D10, University of Crete, Vassilika Voutes, 71110 Heraklion, Crete, Greece
| | - Vassilis Gorgoulis
- Laboratory of Histology & Embryology, School of Medicine, University of Athens, Athens, Greece
| | | | | | - Kenzo Hiroshima
- Department of Pathology, Tokyo Women's Medical University Yachiyo Medical Center, 477-96 Owada-Shinden, Yachiyo-shi, Chiba 276-8524, Japan
| | - Reika Iwakawa
- Division of Multistep Carcinogenesis, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan
| | - Nikolaos G Kastrinakis
- Laboratory of Histology & Embryology, School of Medicine, University of Athens, Athens, Greece
| | - Ichiro Kinoshita
- Department of Medical Oncology, Hokkaido University, Graduate School of Medicine, North 15, West 7, Kita-ku, Sapporo 060-8638, Japan
| | - Suminori Akiba
- Department of Epidemiology and Preventative Medicine, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima, Japan
| | - Maria T Landi
- Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
| | - H Eugene Liu
- Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
| | - Jinn-Li Wang
- Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
| | - Ranee Mehra
- Department of Medical Oncology and Developmental Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA
| | - Fadlo R Khuri
- Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA
| | - Wan-Teck Lim
- Department of Medical Oncology, National Cancer Center Singapore, 11 Hospital Drive, Singapore 169610, Republic of Singapore
| | - Taofeek K Owonikoko
- Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA
| | - Suresh Ramalingam
- Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA
| | - Emmanuela Sarchianaki
- Faculty of Medicine, Laboratory of Clinical Virology, 5D10, University of Crete, Vassilika Voutes, 71110 Heraklion, Crete, Greece
| | - Kari Syrjanen
- Department of Oncology & Radiotherapy, Turku University Hospital, Turku, Finland, Fundação Pio XII- Hospital de Câncer de Barretos, Barretos, Brazil
| | | | - Jenna Sykes
- Department of Biostatistics, University Health Network, Princess Margaret Cancer Centre, Toronto, Ontario M5G2M9, Canada
| | - Siew Wan Hee
- Division of Health Sciences, Warwick Medical School, The University of Warwick, Coventry, UK and
| | - Jun Yokota
- Division of Multistep Carcinogenesis, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan
| | - Apostolos Zaravinos
- Faculty of Medicine, Laboratory of Clinical Virology, 5D10, University of Crete, Vassilika Voutes, 71110 Heraklion, Crete, Greece
| | - Emanuela Taioli
- Department of Population Health, North Shore Long Island Jewish Health System, Hofstra Medical School, The Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, NY, USA
| |
Collapse
|
17
|
Abstract
As pressures mount on efficiency, hip and knee arthroplasty surgery is increasingly being performed during weekends. Despite the growing trend for weekend orthopaedic surgery, there are virtually no published data on the effect of weekend operating on the length of hospital stay (LOS).
Collapse
Affiliation(s)
- D Gibbs
- SpR in Trauma and Orthopaedics, Leicester General Hospital
| | - S Tafazal
- SpR in Trauma and Orthopaedics, Leicester General Hospital
| | - R Handley
- SHO in General Surgery, Christchurch Hospital, New Zealand
| | - M Newey
- Consultant Orthopaedic Surgeon, Leicester General Hospital
| |
Collapse
|
18
|
Ginsburg I, Sadovnik M, Sallon S, Milo-Goldzweig I, Mechoulam R, Breuer A, Gibbs D, Varani J, Roberts S, Cleator E, Singh N. PADMA-28, a traditional tibetan herbal preparation inhibits the respiratory burst in human neutrophils, the killing of epithelial cells by mixtures of oxidants and pro-inflammatory agonists and peroxidation of lipids. Inflammopharmacology 2010; 7:47-62. [PMID: 17657446 DOI: 10.1007/s10787-999-0025-9] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/1998] [Revised: 01/06/1999] [Accepted: 01/07/1999] [Indexed: 10/23/2022]
Abstract
Both aqueous and methanolic fractions derived from the Tibetan preparation PADMA-28 (a mixture of 22 plants) used as an anti-atherosclerotic agent, and which is non-cytolytic to a variety of mammalian cells, were found to strongly inhibit (1) the killing of epithelial cells in culture induced by 'cocktails' comprising oxidants, membrane perforating agents and proteinases; (2) the generation of luminol-dependent chemiluminescence in human neutrophils stimulated by opsonized bacteria; (3) the peroxidation of intralipid (a preparation rich in phopholipids) induced in the presence of copper; and (4) the activity of neutrophil elastase. It is proposed that PADMA-28 might prove beneficial for the prevention of cell damage induced by synergism among pro-inflammatory agonists which is central in the initiation of tissue destruction in inflammatory and infectious conditions.
Collapse
Affiliation(s)
- I Ginsburg
- Department of Oral Biology, Hebrew University-Hadassah School of Dental medicine, Jerusalem, Israel
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Tebbutt N, Sourjina T, Strickland A, Van Hazel G, Ganju V, Gibbs D, Gebski V, Munro S, Cummins M. ATTAX: Randomised phase II study evaluating weekly docetaxel-based chemotherapy combinations in advanced esophago- gastric cancer, final results of an AGITG trial. J Clin Oncol 2007. [DOI: 10.1200/jco.2007.25.18_suppl.4528] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
4528 Background: Docetaxel (T), cisplatin (C) and 5FU(F) are active agents in esophago-gastric cancer. A recent phase III study evaluating 3-weekly TCF demonstrated a survival advantage over standard therapy, but TCF was associated with high rates of hematological toxicity (30% incidence of febrile neutropenia/neutropenic infection) as well as non-hematological side effects (Van Cutsem et al, J. Clin Oncol. 24 4991–4997 2006). Weekly docetaxel is associated with a lower incidence of hematological toxicity. This randomized phase II study aimed to test weekly docetaxel based combination chemotherapy regimens with the aim of maintaining the activity of such regimens but reducing toxicity. Methods: Eligibility included; histologically confirmed, metastatic esophageal or gastric (OG) carcinoma, measurable disease, PS0–2, adequate organ function, no prior treatment, informed consent. Patients (Pts) were randomized to receive weekly (w) T 30mg/m2 d1,8 C 60 mg/m2 d1 F 200 mg/m2/d continuously q 3w or wT 30 mg/m2 d1,d8 and capecitabine (X)1,600 mg/m2/d d1–14 q3w. The primary endpoint is confirmed response rate (RR), with each arm analyzed independently. Simon’s 2-stage design was used, with 5/21 responses required in the first stage to allow continuation to 50 pts per arm. Results: Response rates in each arm satisfied the first stage, and complete accrual of 106 pts was completed in May 2006. Demographics, toxicity and response rates are shown in the table . With a median follow-up of 14.6 months, progression free and overall survival times are 5.9 m and 12.8 m, and 4.2m and 10.1 m for wTCF and wTX, respectively. Conclusions: wTCF and wTX have encouraging activity and a far more favorable toxicity profile than TCF administered 3-weekly. Weekly docetaxel-based combination regimens should be evaluated further in this disease. [Table: see text] [Table: see text]
Collapse
Affiliation(s)
- N. Tebbutt
- Austin Health, Melbourne, Australia; NHMRC Clinical Trials Centre, Sydney, Australia; Monash Medical Centre, Melbourne, Australia; Sir Charles Gairdner Hospital, Perth, Australia; Frankston Hospital, Melbourne, Australia; Christchurch Hospital, Christchurch, New Zealand
| | - T. Sourjina
- Austin Health, Melbourne, Australia; NHMRC Clinical Trials Centre, Sydney, Australia; Monash Medical Centre, Melbourne, Australia; Sir Charles Gairdner Hospital, Perth, Australia; Frankston Hospital, Melbourne, Australia; Christchurch Hospital, Christchurch, New Zealand
| | - A. Strickland
- Austin Health, Melbourne, Australia; NHMRC Clinical Trials Centre, Sydney, Australia; Monash Medical Centre, Melbourne, Australia; Sir Charles Gairdner Hospital, Perth, Australia; Frankston Hospital, Melbourne, Australia; Christchurch Hospital, Christchurch, New Zealand
| | - G. Van Hazel
- Austin Health, Melbourne, Australia; NHMRC Clinical Trials Centre, Sydney, Australia; Monash Medical Centre, Melbourne, Australia; Sir Charles Gairdner Hospital, Perth, Australia; Frankston Hospital, Melbourne, Australia; Christchurch Hospital, Christchurch, New Zealand
| | - V. Ganju
- Austin Health, Melbourne, Australia; NHMRC Clinical Trials Centre, Sydney, Australia; Monash Medical Centre, Melbourne, Australia; Sir Charles Gairdner Hospital, Perth, Australia; Frankston Hospital, Melbourne, Australia; Christchurch Hospital, Christchurch, New Zealand
| | - D. Gibbs
- Austin Health, Melbourne, Australia; NHMRC Clinical Trials Centre, Sydney, Australia; Monash Medical Centre, Melbourne, Australia; Sir Charles Gairdner Hospital, Perth, Australia; Frankston Hospital, Melbourne, Australia; Christchurch Hospital, Christchurch, New Zealand
| | - V. Gebski
- Austin Health, Melbourne, Australia; NHMRC Clinical Trials Centre, Sydney, Australia; Monash Medical Centre, Melbourne, Australia; Sir Charles Gairdner Hospital, Perth, Australia; Frankston Hospital, Melbourne, Australia; Christchurch Hospital, Christchurch, New Zealand
| | - S. Munro
- Austin Health, Melbourne, Australia; NHMRC Clinical Trials Centre, Sydney, Australia; Monash Medical Centre, Melbourne, Australia; Sir Charles Gairdner Hospital, Perth, Australia; Frankston Hospital, Melbourne, Australia; Christchurch Hospital, Christchurch, New Zealand
| | - M. Cummins
- Austin Health, Melbourne, Australia; NHMRC Clinical Trials Centre, Sydney, Australia; Monash Medical Centre, Melbourne, Australia; Sir Charles Gairdner Hospital, Perth, Australia; Frankston Hospital, Melbourne, Australia; Christchurch Hospital, Christchurch, New Zealand
| |
Collapse
|
20
|
Hashimoto T, Gibbs D, Lillo C, Azarian SM, Legacki E, Zhang XM, Yang XJ, Williams DS. Lentiviral gene replacement therapy of retinas in a mouse model for Usher syndrome type 1B. Gene Ther 2007; 14:584-94. [PMID: 17268537 PMCID: PMC9307148 DOI: 10.1038/sj.gt.3302897] [Citation(s) in RCA: 90] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
One of the most disabling forms of retinal degeneration occurs in Usher syndrome, since it affects patients who already suffer from deafness. Mutations in the myosin VIIa gene (MYO7A) cause a major subtype of Usher syndrome, type 1B. Owing to the loss of function nature of Usher 1B and the relatively large size of MYO7A, we investigated a lentiviral-based gene replacement therapy in the retinas of MYO7A-null mice. Among the different promoters tested, a CMV-MYO7A chimeric promoter produced wild-type levels of MYO7A in cultured RPE cells and retinas in vivo. Efficacy of the lentiviral therapy was tested by using cell-based assays to analyze the correction of previously defined, MYO7A-null phenotypes in the mouse retina. In vitro, defects in phagosome digestion and melanosome motility were rescued in primary cultures of RPE cells. In vivo, the normal apical location of melanosomes in RPE cells was restored, and the abnormal accumulation of opsin in the photoreceptor connecting cilium was corrected. These results demonstrate that a lentiviral vector can accommodate a large cDNA, such as MYO7A, and mediate correction of important cellular functions in the retina, a major site affected in the Usher syndrome. Therefore, a lentiviral-mediated gene replacement strategy for Usher 1B therapy in the retina appears feasible.
Collapse
Affiliation(s)
- T Hashimoto
- Jules Stein Eye Institute, Molecular Biology Institute, UCLA School of Medicine, Los Angeles, CA, USA
| | - D Gibbs
- Departments of Pharmacology and Neurosciences, UCSD School of Medicine, La Jolla, CA, USA
| | - C Lillo
- Departments of Pharmacology and Neurosciences, UCSD School of Medicine, La Jolla, CA, USA
| | - SM Azarian
- Departments of Pharmacology and Neurosciences, UCSD School of Medicine, La Jolla, CA, USA
| | - E Legacki
- Departments of Pharmacology and Neurosciences, UCSD School of Medicine, La Jolla, CA, USA
| | - X-M Zhang
- Jules Stein Eye Institute, Molecular Biology Institute, UCLA School of Medicine, Los Angeles, CA, USA
| | - X-J Yang
- Jules Stein Eye Institute, Molecular Biology Institute, UCLA School of Medicine, Los Angeles, CA, USA
| | - DS Williams
- Departments of Pharmacology and Neurosciences, UCSD School of Medicine, La Jolla, CA, USA
| |
Collapse
|
21
|
Espinel-Ingroff A, Canton E, Gibbs D, Wang A. Correlation of Neo-Sensitabs tablet diffusion assay results on three different agar media with CLSI broth microdilution M27-A2 and disk diffusion M44-A results for testing susceptibilities of Candida spp. and Cryptococcus neoformans to amphotericin B, caspofungin, fluconazole, itraconazole, and voriconazole. J Clin Microbiol 2007; 45:858-64. [PMID: 17215342 PMCID: PMC1829139 DOI: 10.1128/jcm.01900-06] [Citation(s) in RCA: 44] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
We compared the Neo-Sensitabs tablet assay to both reference M27-A2 broth microdilution and M44-A disk diffusion methods for testing susceptibilities of 110 isolates of Candida spp. and Cryptococcus neoformans to amphotericin B, caspofungin, fluconazole, itraconazole, and voriconazole. Neo-Sensitabs assay inhibition zone diameters in millimeters on three agars (Mueller-Hinton agar supplemented with 2% dextrose and 0.5 microg/ml methylene blue [MGM], Shadomy [SHA], and RPMI 1640 [RPMI, 2% dextrose]) were obtained at 24 to 72 h. The correlation coefficient of Neo-Sensitabs results with MICs was similar to that of the disk method for most of the five agents on MGM (R, 0.80 to 0.89 versus 0.76 to 0.89, respectively). Overall, superior correlation was observed at 24 h for most agents. The exception was amphotericin B (R values of 0.68 and 0.5 for disk and tablet, respectively, at 48 h versus 0.68 and 0.48, respectively, at 24 h). In general, Neo-Sensitabs results were less consistent on SHA and RPMI agars. Although agreement by breakpoint category of Neo-Sensitabs and disk results with CLSI method M27-A2 was also similar on MGM (92.7 to 98.2% versus 95.5 to 100%, respectively), the Neo-Sensitabs method failed to identify two of the six isolates with high amphotericin B MICs. These data suggest the potential value of the Neo-Sensitabs assay for testing at least four of the five agents against yeasts evaluated in the clinical laboratory.
Collapse
Affiliation(s)
- A Espinel-Ingroff
- Division of Infectious Diseases, VCU Medical Center, 1101 Marshal St., Sanger Hall, Room 7049, Richmond, VA 23298-0049, USA.
| | | | | | | |
Collapse
|
22
|
Tebbutt N, Gebski V, Strickland A, Gibbs D, Walpole E, Ganju V, Goldstein D, Munro S, Harrod M, Van Hazel G. Randomised phase II study evaluating weekly docetaxel in combination with cisplatin and 5FU or capecitabine in metastatic oesophago-gastric cancer. J Clin Oncol 2006. [DOI: 10.1200/jco.2006.24.18_suppl.4067] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
4067 Background: Docetaxel (T), cisplatin (C) and 5FU (F) are active agents in oesophago-gastric cancer. A recent phase III study using TCF achieved a survival advantage but was associated with high rates of haematological toxicity (30% incidence of febrile neutropenia/neutropenic infection) as well as non-haematological side effects (Moiseyenko et al, 2005 Pr ASCO abstr 4002). Weekly docetaxel is associated with a lower incidence of haematological toxicity. This randomised phase II study aimed to test weekly docetaxel based combination chemotherapy regimens with the aim of maintaining the activity of docetaxel based combination regimens but reducing toxicity. Methods: Eligibility included; histologically confirmed, metastatic oesophageal or gastric (OG) carcinoma, measurable disease, PS0–2, adequate organ function, no prior treatment, informed consent. Pts were randomised to receive weekly (w) T 30 mg/m2 d1, 8 C 60 mg/m2 d1 F 200 mg/m2/d continuously q 3w or wT 30 mg/m2 d1, d8 and capecitabine (×)1600 mg/m2/d d1–14 q3w. The primary endpoint is confirmed response rate (RR), with each arm analysed independently. Simon’s 2 stage design was used, with 5/21 responses required in the first stage to allow continuation to 48 pts per arm. Results: 79 pts enrolled to date. Protocol specified interim analysis of efficacy after 21 pts per arm and of toxicity after 25 pts per arm ( Table ). In the first 21 pts per arm; 12 responses (11 confirmed) in wTCF arm, 6 responses (5 confirmed) in wTX arm. Trial continues accrual to target of 48 pts per arm. Complete accrual expected by April 2006. Updated data will be presented at the meeting. Conclusions: wTCF and wTX have encouraging activity and and a more favourable toxicity profile than TCF administered 3-weekly. [Table: see text] [Table: see text]
Collapse
Affiliation(s)
- N. Tebbutt
- Austin Health, Melbourne, Australia; NHMRC Clinical Trials Centre, Sydney, Australia; Monash Medical Centre, Melbourne, Australia; Christchurch Hospital, Christchurch, New Zealand; Princess Alexandra Hospital, Brisbane, Australia; Frankston Hospital, Melbourne, Australia; Prince of Wales Hospital, Sydney, Australia; Sir Charles Gairdner Hospital, Perth, Australia
| | - V. Gebski
- Austin Health, Melbourne, Australia; NHMRC Clinical Trials Centre, Sydney, Australia; Monash Medical Centre, Melbourne, Australia; Christchurch Hospital, Christchurch, New Zealand; Princess Alexandra Hospital, Brisbane, Australia; Frankston Hospital, Melbourne, Australia; Prince of Wales Hospital, Sydney, Australia; Sir Charles Gairdner Hospital, Perth, Australia
| | - A. Strickland
- Austin Health, Melbourne, Australia; NHMRC Clinical Trials Centre, Sydney, Australia; Monash Medical Centre, Melbourne, Australia; Christchurch Hospital, Christchurch, New Zealand; Princess Alexandra Hospital, Brisbane, Australia; Frankston Hospital, Melbourne, Australia; Prince of Wales Hospital, Sydney, Australia; Sir Charles Gairdner Hospital, Perth, Australia
| | - D. Gibbs
- Austin Health, Melbourne, Australia; NHMRC Clinical Trials Centre, Sydney, Australia; Monash Medical Centre, Melbourne, Australia; Christchurch Hospital, Christchurch, New Zealand; Princess Alexandra Hospital, Brisbane, Australia; Frankston Hospital, Melbourne, Australia; Prince of Wales Hospital, Sydney, Australia; Sir Charles Gairdner Hospital, Perth, Australia
| | - E. Walpole
- Austin Health, Melbourne, Australia; NHMRC Clinical Trials Centre, Sydney, Australia; Monash Medical Centre, Melbourne, Australia; Christchurch Hospital, Christchurch, New Zealand; Princess Alexandra Hospital, Brisbane, Australia; Frankston Hospital, Melbourne, Australia; Prince of Wales Hospital, Sydney, Australia; Sir Charles Gairdner Hospital, Perth, Australia
| | - V. Ganju
- Austin Health, Melbourne, Australia; NHMRC Clinical Trials Centre, Sydney, Australia; Monash Medical Centre, Melbourne, Australia; Christchurch Hospital, Christchurch, New Zealand; Princess Alexandra Hospital, Brisbane, Australia; Frankston Hospital, Melbourne, Australia; Prince of Wales Hospital, Sydney, Australia; Sir Charles Gairdner Hospital, Perth, Australia
| | - D. Goldstein
- Austin Health, Melbourne, Australia; NHMRC Clinical Trials Centre, Sydney, Australia; Monash Medical Centre, Melbourne, Australia; Christchurch Hospital, Christchurch, New Zealand; Princess Alexandra Hospital, Brisbane, Australia; Frankston Hospital, Melbourne, Australia; Prince of Wales Hospital, Sydney, Australia; Sir Charles Gairdner Hospital, Perth, Australia
| | - S. Munro
- Austin Health, Melbourne, Australia; NHMRC Clinical Trials Centre, Sydney, Australia; Monash Medical Centre, Melbourne, Australia; Christchurch Hospital, Christchurch, New Zealand; Princess Alexandra Hospital, Brisbane, Australia; Frankston Hospital, Melbourne, Australia; Prince of Wales Hospital, Sydney, Australia; Sir Charles Gairdner Hospital, Perth, Australia
| | - M. Harrod
- Austin Health, Melbourne, Australia; NHMRC Clinical Trials Centre, Sydney, Australia; Monash Medical Centre, Melbourne, Australia; Christchurch Hospital, Christchurch, New Zealand; Princess Alexandra Hospital, Brisbane, Australia; Frankston Hospital, Melbourne, Australia; Prince of Wales Hospital, Sydney, Australia; Sir Charles Gairdner Hospital, Perth, Australia
| | - G. Van Hazel
- Austin Health, Melbourne, Australia; NHMRC Clinical Trials Centre, Sydney, Australia; Monash Medical Centre, Melbourne, Australia; Christchurch Hospital, Christchurch, New Zealand; Princess Alexandra Hospital, Brisbane, Australia; Frankston Hospital, Melbourne, Australia; Prince of Wales Hospital, Sydney, Australia; Sir Charles Gairdner Hospital, Perth, Australia
| |
Collapse
|
23
|
Stark C, Gibbs D, Hopkins P, Belbin A, Hay A, Selvaraj S. Suicide in farmers in Scotland. Rural Remote Health 2006; 6:509. [PMID: 16563050] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/08/2023] Open
Abstract
INTRODUCTION Farmers and farm workers have higher than expected rates of suicide and undetermined deaths in UK studies, and some rural areas of Scotland have higher than average male suicide rates. Firearm access seems to be an influencing factor in England and Wales. Type of farming, and farming social networks may also be important. This article describes suicide and undetermined deaths in male farmers and farm workers in Scotland from 1981-1999 using anonymised, routine data. METHOD Deaths of men aged 15-74 years from suicide or undetermined cause were identified from anonymised Scottish death records. Farmers and farm workers were identified using occupation codes. Methods of suicide used by farmers were compared with those of the general male population of the same age. A multiple linear regression was used to examine the influence of farm type, and the proportion of farmers in the working population of an area. RESULTS 307 male farmers or farm workers died by suicide or undetermined cause in the time period. The overall rate was 31.4/100,000 per year (95% CI 28.1-35.1). Deaths using firearms were over-represented (29% of farming deaths compared with 3.6% in the general male population). There was no significant association between the male suicide rate in an area, and the farming suicide rate. Areas with lower proportions of farmers tended to have higher rates of farming suicide and undetermined deaths. This one factor described 85% of the variance among areas. CONCLUSION Deaths were substantially more likely to involve firearms than suicide and undetermined deaths in the general male population. Less use of other methods did not completely compensate for this, indicating that method availability is likely to contribute to farming suicide rates. Farmers in areas where farming is less common were more likely to die by suicide, and this described most of the differences among areas. Networks and social supports may be important protective factors for farmers.
Collapse
Affiliation(s)
- C Stark
- Centre for Rural Health, University of Aberdeen, The Green House, Beechwood Business Park North, Inverness, Scotland.
| | | | | | | | | | | |
Collapse
|
24
|
Milne TA, Hughes CM, Lloyd R, Yang Z, Rozenblatt-Rosen O, Dou Y, Schnepp RW, Krankel C, Livolsi VA, Gibbs D, Hua X, Roeder RG, Meyerson M, Hess JL. Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. Proc Natl Acad Sci U S A 2005; 102:749-54. [PMID: 15640349 PMCID: PMC545577 DOI: 10.1073/pnas.0408836102] [Citation(s) in RCA: 339] [Impact Index Per Article: 17.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
Mutations in the MEN1 gene are associated with the multiple endocrine neoplasia syndrome type 1 (MEN1), which is characterized by parathyroid hyperplasia and tumors of the pituitary and pancreatic islets. The mechanism by which MEN1 acts as a tumor suppressor is unclear. We have recently shown that menin, the MEN1 protein product, interacts with mixed lineage leukemia (MLL) family proteins in a histone methyltransferase complex including Ash2, Rbbp5, and WDR5. Here, we show that menin directly regulates expression of the cyclin-dependent kinase inhibitors p27Kip1 and p18Ink4c. Menin activates transcription by means of a mechanism involving recruitment of MLL to the p27Kip1 and p18Ink4c promoters and coding regions. Loss of function of either MLL or menin results in down-regulation of p27Kip1 and p18Ink4c expression and deregulated cell growth. These findings suggest that regulation of cyclin-dependent kinase inhibitor transcription by cooperative interaction between menin and MLL plays a central role in menin's activity as a tumor suppressor.
Collapse
Affiliation(s)
- Thomas A Milne
- Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Abstract
MLL fusion proteins are leukemogenic, but their mechanism is unclear. Induced dimerization of a truncated MLL immortalizes bone marrow and imposes a reversible block on myeloid differentiation associated with upregulation of Hox a7, a9, and Meis1. Both dimerized MLL and exon-duplicated MLL are potent transcriptional activators, suggesting a link between dimerization and partial tandem duplication of DNA binding domains of MLL. Dimerized MLL binds with higher affinity than undimerized MLL to a CpG island within the Hox a9 locus. However, MLL-AF9 is not dimerized in vivo. The data support a model in which either MLL dimerization/exon duplication or fusion to a transcriptional activator results in Hox gene upregulation and ultimately transformation.
Collapse
Affiliation(s)
- Mary Ellen Martin
- Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Abstract
MLL, the human homolog of Drosophila trithorax, maintains Hox gene expression in mammalian embryos and is rearranged in human leukemias resulting in Hox gene deregulation. How MLL or MLL fusion proteins regulate gene expression remains obscure. We show that MLL regulates target Hox gene expression through direct binding to promoter sequences. We further show that the MLL SET domain is a histone H3 lysine 4-specific methyltransferase whose activity is stimulated with acetylated H3 peptides. This methylase activity is associated with Hox gene activation and H3 (Lys4) methylation at cis-regulatory sequences in vivo. A leukemogenic MLL fusion protein that activates Hox expression had no effect on histone methylation, suggesting a distinct mechanism for gene regulation by MLL and MLL fusion proteins.
Collapse
Affiliation(s)
- Thomas A Milne
- Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
| | | | | | | | | | | | | |
Collapse
|
27
|
Coventry BJ, Lee PL, Gibbs D, Hart DNJ. Dendritic cell density and activation status in human breast cancer -- CD1a, CMRF-44, CMRF-56 and CD-83 expression. Br J Cancer 2002; 86:546-51. [PMID: 11870535 PMCID: PMC2375292 DOI: 10.1038/sj.bjc.6600132] [Citation(s) in RCA: 49] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2001] [Accepted: 12/04/2001] [Indexed: 11/26/2022] Open
Abstract
Low CD1a-positive putative dendritic cell numbers in human breast cancer has recently been described and may explain the apparent 'poor immunogenicity' previously reported in breast cancer. Little attention has been given to dendritic cell activation within the tumour microenvironment, which is another reason why the in-situ immune response may be severely deficient. We have therefore examined CD1a expression as a marker for dendritic cells, together with CMRF-44 and -56 as markers of dendritic cell activation status, in 40 human breast cancers. The results demonstrate few or no CD1a-positive putative dendritic cells and minimal or no expression of the dendritic cell activation markers. Both dendritic cell number and dendritic cell activation appear substantially deficient in human breast cancers, regardless of tumour histological grade.
Collapse
Affiliation(s)
- B J Coventry
- Department of Surgery, University of Adelaide, Royal Adelaide Hospital, North Terrace, Adelaide, South Australia 5000, Australia.
| | | | | | | |
Collapse
|
28
|
McCormack LA, Burrus BB, Garfinkel SA, Gibbs D, Harris-Kojetin LD, Sangl JA. Providing information to help Medicare beneficiaries choose a health plan. J Aging Soc Policy 2001; 12:49-72. [PMID: 11303366 DOI: 10.1300/j031v12n02_04] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
Many Medicare beneficiaries have limited knowledge of the Medicare program and related health insurance options. This is due in part to the complexity of the Medicare program and supplemental health insurance market. A recent congressional mandate through the Balanced Budget Act of 1997 called for broad dissemination of information to educate beneficiaries about their health plan options and to encourage informed health plan decision-making. In response, the Health Care Financing Administration (HCFA) launched the National Medicare Education Program (NMEP) to support the educational objectives of the BBA. This paper provides an overview of the components of the NMEP information campaign. We also review lessons learned from our experience in designing and testing a prototype consumer handbook that explains the different health plan options to Medicare beneficiaries. Through our discussion of the handbook, we highlight several ways to communicate information effectively about a complex publicly funded program to an older adult population.
Collapse
Affiliation(s)
- L A McCormack
- Research Triangle Institute, Health and Social Policy Division, P.O. Box 1219, 3040 Cornwallis Road, Cox Building, Room 163, Research Triangle Park, NC 27709-2194, USA.
| | | | | | | | | | | |
Collapse
|
29
|
Liovic M, Stojan J, Bowden PE, Gibbs D, Vahlquist A, Lane EB, Komel R. A novel keratin 5 mutation (K5V186L) in a family with EBS-K: a conservative substitution can lead to development of different disease phenotypes. J Invest Dermatol 2001; 116:964-9. [PMID: 11407988 DOI: 10.1046/j.1523-1747.2001.01334.x] [Citation(s) in RCA: 44] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Epidermolysis bullosa simplex is a hereditary skin blistering disorder caused by mutations in the KRT5 or KRT14 genes. More than 50 different mutations have been described so far. These, and reports of other keratin gene mutations, have highlighted the existence of mutation "hotspots" in keratin proteins at which sequence changes are most likely to be detrimental to protein function. Pathogenic mutations that occur outside these hotspots are usually associated with less severe disease phenotypes. We describe a novel K5 mutation (V186L) that produces a conservative amino acid change (valine to leucine) at position 18 of the 1A helix. The phenotype of this case is unexpectedly severe for the location of the mutation, which lies outside the consensus helix initiation motif mutation hotspot, and other mutations at this position have been associated in Weber--Cockayne (mild) epidermolysis bullosa simplex only. The mutation was confirmed by mismatch-allele-specific polymerase chain reaction and the entire KRT5 coding region was sequenced, but no other changes were identified. De novo K5/K14 (mutant and wild-type) filament assembly in cultured cells was studied to determine the effect of this mutation on filament polymerization and stability. A computer model of the 1A region of the K5/K14 coiled-coil was generated to visualize the structural impact of this mutation and to compare it with an analogous mutation causing mild disease. The results show a high level of concordance between genetic, cell culture and molecular modeling data, suggesting that even a conservative substitution can cause severe dysfunction in a structural protein, depending on the size and structure of the amino acid involved.
Collapse
Affiliation(s)
- M Liovic
- Medical Center for Molecular Biology, University of Ljubljana, Ljubljana, Slovenia
| | | | | | | | | | | | | |
Collapse
|
30
|
Liebowitz LD, Ashbee HR, Evans EG, Chong Y, Mallatova N, Zaidi M, Gibbs D. A two year global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion. Diagn Microbiol Infect Dis 2001; 40:27-33. [PMID: 11448560 DOI: 10.1016/s0732-8893(01)00243-7] [Citation(s) in RCA: 107] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
The in-vitro activity of fluconazole against 46,831 yeast isolates collected over a two-year period from 57 laboratories in 33 countries worldwide was assessed using a disc diffusion method. Candida albicans was the organism isolated most frequently, accounting for 68.6% of the total number of isolates. C. glabrata, C. tropicalis, C parapsilosis and C. krusei and Cryptococcus neoformans represented 9.9, 4.7, 4.3, 1.9, and 1.4% of isolates respectively during the 2 year period and rates varied markedly between countries. In 1999 data blood isolates represented 4.9% of all isolates and intensive care unit isolates represented 9.9%. In both the 1998 and 1999 data, 99% of C. albicans were fully susceptible (S) to fluconazole, and 95.6% of all species of yeasts tested were S or susceptible-dose dependent (S-DD) to fluconazole. No emerging trends of resistance were noted with any of the Candida spp. tested as 96% of all isolates retained susceptibility (S or S-DD) to this agent.
Collapse
Affiliation(s)
- L D Liebowitz
- Department of Medical Microbiology, University of the Witwatersrand and SAIMR, P.O. Box 1038, 2000, Johannesburg, South Africa
| | | | | | | | | | | | | |
Collapse
|
31
|
Nakao H, Ohwada K, Takesue N, Fujii Y, Isobe M, Ueda Y, Zimmermann M, Hill JP, Gibbs D, Woicik JC, Koyama I, Murakami Y. X-Ray anomalous scattering study of a charge-ordered state in NaV2O5. Phys Rev Lett 2000; 85:4349-4352. [PMID: 11060635 DOI: 10.1103/physrevlett.85.4349] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/13/2000] [Indexed: 05/23/2023]
Abstract
Charge ordering of V4+ and V5+ in NaV2O5 has been studied by an x-ray diffraction technique using anomalous scattering near a vanadium K-absorption edge to critically enhance a contrast between the two ions. A dramatic energy dependence of the superlattice intensities is observed below T(C) = 35 K. The charge ordering pattern is the fully charged zigzag-type ladder with the unit cell 2ax2bx4c, but not the chain-type originally proposed for the spin-Peierls state. Charge disproportionation suggested in our model as the average valence V(4.5+/-delta(c)/2) is observed below T(C), showing continuous variation of delta(c) as a function of temperature.
Collapse
Affiliation(s)
- H Nakao
- Neutron Scattering Laboratory, Institute for Solid State Physics, The University of Tokyo, 106-1 Shirakata, Tokai, Ibaraki 319-1106, Japan
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Keimer B, Casa D, Ivanov A, Lynn JW, Zimmermann M, Hill JP, Gibbs D, Taguchi Y, Tokura Y. Spin dynamics and orbital state in LaTiO3. Phys Rev Lett 2000; 85:3946-3949. [PMID: 11041967 DOI: 10.1103/physrevlett.85.3946] [Citation(s) in RCA: 42] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/02/2000] [Indexed: 05/23/2023]
Abstract
A neutron scattering study of the Mott-Hubbard insulator LaTiO3 ( T(N) = 132 K) reveals a spin wave spectrum that is well described by a nearest-neighbor superexchange constant J = 15.5 meV and a small Dzyaloshinskii-Moriya interaction ( D = 1.1 meV). The nearly isotropic spin wave spectrum is surprising in view of the absence of a static Jahn-Teller distortion that could quench the orbital angular momentum, and it may indicate strong orbital fluctuations. A resonant x-ray scattering study has uncovered no evidence of orbital order in LaTiO3.
Collapse
Affiliation(s)
- B Keimer
- Max-Planck-Institut fur Festkorperforschung, 70569 Stuttgart, Germany and Department of Physics, Princeton University, Princeton, New Jersey 08544, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
33
|
Gibbs D. Drawings of changes in scrofulous glands by Frederick Treves. J R Soc Med 2000; 93:550-1. [PMID: 11064700 PMCID: PMC1298136 DOI: 10.1177/014107680009301018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
34
|
Meis J, Petrou M, Bille J, Ellis D, Gibbs D. A global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion. Global Antifungal Surveillance Group. Diagn Microbiol Infect Dis 2000; 36:215-23. [PMID: 10764963 DOI: 10.1016/s0732-8893(99)00152-2] [Citation(s) in RCA: 54] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
An improved fluconazole 25-mg disk diffusion method was used to test the susceptibility of 20,900 consecutively isolated clinical strains of Candida species from 40 hospital laboratories in 26 countries. The procedure is similar to the National Committee for Clinical Laboratory Standards (NCCLS) M2-A6 method for testing bacteria, except Mueller-Hinton agar is supplemented with 2% glucose and 0.5 mcg/mL methylene blue. Plates were incubated at 35 degrees C and read after 18 to 24h. Tentative zone interpretive criteria were based on the correlation by regression analysis with the NCCLS M27-A Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: > =19mm Susceptible, < = 12mm Resistant, and 13-18 mm Susceptible-Dose Dependent. Of 14,368 isolates of Candida albicans, 2,073 C. glabrata, 869 C. tropicalis, 752 C. parapsilosis, and 351 C. krusei, 99%, 67%, 90%, 94%, and 26%, respectively, were susceptible in vitro to fluconazole. All study sites used the BIOMIC System to electronically read zones on plates, interpret, record test results and verify quality control data. This is the largest study to date that evaluated a broad range of sequentially collected yeasts from various infections and different types of hospitals. The modified disk testing procedure is facile and economical to perform and offers a reproducible and accurate means to assess the in vitro susceptibility of Candida species to fluconazole.
Collapse
Affiliation(s)
- J Meis
- Medical Microbiology, University Hospital, G. Grooteplein Zuid 24, 6525 GA, Nijmegen, Netherlands
| | | | | | | | | |
Collapse
|
35
|
Gibbs D. When a cane was the necessary complement of a physician. J R Coll Physicians Lond 1999; 33:85-9. [PMID: 10192077 PMCID: PMC9665833] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/11/2023]
Abstract
Although Dr John Radcliffe's gold-headed cane, presented to the Royal College of Physicians in 1825, became well-known following the publication two years later of Dr William Macmichael's book, The gold-headed cane, little consideration has previously been given either to medical canes, or to the custom of cane-carrying by doctors in the 18th century. This article makes a brief assessment of medical canes within the social and historical framework of the period, and views Macmichael's book in its literary context, with mention of other relevant examples of books in this genre.
Collapse
|
36
|
Daniels DE, Smith K, Parks-Thomas T, Gibbs D, Robinson J. Organ and tissue donation: are minorities willing to donate? Ann Transplant 1998; 3:22-4. [PMID: 9869886] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/09/2023] Open
Abstract
The Task Force on Organ Transplantation (DHHS,1986) addressed the issue of increasing organ donation. The Report of the Task Force recommended that "educational efforts aimed at increasing organ donation among minority populations be developed and implemented, so that the donor population will more closely reflect the ethnicity of potential transplant recipients, in order to gain the advantage of improved donor and recipient immunologic matching (DHHS,1986). Donor rates for minorities has increased as follows: 16% in 1988 to 23% in 1995 among cadaveric donors and 24% in 1988 to 28% in 1995 among living donors. The improvement in donor rates among minorities may positively affect the transplantation success rate experienced by organ recipients of the same race. Strategies must be implemented that will increase the effectiveness and frequency of communication between minority patients and the medical community. An increase in the effectiveness of communication between potential minority donor families and the health care community will contribute to the process of Consciousness Raising as discussed by Prochasksa. The result of increased awareness of the organ donation and transplantation process may have a favorable impact on organ donation. The media has, through public service announcements, paid advertising and entertainment programming, attempted to promote discussion of organ donation in the community and within families. Johnson et al. discussed Mexican-American and Anglo-American Attitudes Toward Organ Donation. The primary impediment contributing to the disparity of consent rates between Mexican-American and Anglo-American population occurs with regard to the donation of organs of relatives. Johnson stated that this impediment to organ donation can be effectively addressed by promoting family discussion. Communication within families will inform surviving next of kin of the desire of the deceased to be an organ donor and hence improve the likelihood of the donor family consenting to organ donation (Johnson et al., 1988). The promotion of communication within families must continue to be a goal of the transplant community regardless of race/ethnicity. Despite the efforts of the government, the transplant community, the media and the corporate sector to address the critical shortage of donors in the United States, the reality is that no community has the supply of donor organs suitable to meet the need.
Collapse
Affiliation(s)
- D E Daniels
- Department of Applied Health Science at Indiana University, Bloomington, USA
| | | | | | | | | |
Collapse
|
37
|
Vandercam B, Gibbs D, Valtonen M, Jäger H, Armignacco O. Fluconazole orally dispersible tablets for the treatment of patients with oropharyngeal candidiasis. J Int Med Res 1998; 26:209-18. [PMID: 9818788 DOI: 10.1177/030006059802600406] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
The efficacy and tolerability of fluconazole orally dispersible tablets (ODT) in the treatment of oropharyngeal candidiasis was evaluated in this multicentre non-comparative study. A total of 89 adults with signs and symptoms of oropharyngeal candidiasis were enrolled; 70 of whom completed therapy with fluconazole ODT 100 mg once daily for 7 - 14 days. Acquired immunodeficiency syndrome (AIDS)/ AIDS-related complex was an underlying illness in 69% of patients (61). An antimicrobial and corticosteroid therapy was given in 52% (46) and 20% (18) of patients, respectively. Of the 60 patients who had baseline signs and symptoms of infection and a culture positive for Candida albicans, 90% (54) were cured or had improved at the end of therapy, and the fungal pathogen was eradicated in 19/57 (33%) patients. At the 4-week posttreatment follow-up, signs and symptoms of oropharyngeal candidiasis were absent in 73% (27/37) patients. The adverse events and laboratory abnormalities recorded during the study period were attributable to underlying illnesses rather than to fluconazole therapy. These results indicate that this novel dosage form of fluconazole is effective and well tolerated in the treatment of oropharyngeal candidiasis.
Collapse
Affiliation(s)
- B Vandercam
- Department of Internal Medicine, St Luc University Hospital, Brussels, Belgium
| | | | | | | | | |
Collapse
|
38
|
Gibbs D. Queen Alexandra, Niels Finsen and the London Hospital: enlightened links. J Med Biogr 1998; 6:140. [PMID: 11620436 DOI: 10.1177/096777209800600304] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
|
39
|
Sundar S, Kumar P, Makharia M, Goyal A, Rogers M, Gibbs D, Murray H. Atovaquone alone or with fluconazole as oral therapy for Indian kala-azar. Clin Infect Dis 1998; 27:215-6. [PMID: 9675482 DOI: 10.1086/517679] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Affiliation(s)
- S Sundar
- Kala-Azar Medical Research Center, Banaras Hindu University, Varanasi, India
| | | | | | | | | | | | | |
Collapse
|
40
|
Martin DF, Ferris FL, Parks DJ, Walton RC, Mellow SD, Gibbs D, Remaley NA, Ashton P, Davis MD, Chan CC, Nussenblatt RB. Ganciclovir implant exchange. Timing, surgical procedure, and complications. Arch Ophthalmol 1997; 115:1389-94. [PMID: 9366668 DOI: 10.1001/archopht.1997.01100160559005] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
BACKGROUND The ganciclovir implant is effective for the treatment of cytomegalovirus (CMV) retinitis. The device eventually runs out of drug, however, and must be replaced. We report our experience with exchanging ganciclovir implants during the course of a randomized clinical trial. METHODS During our study, patients with newly diagnosed peripheral CMV retinitis were treated with a ganciclovir implant. The implant was scheduled for exchange at 32 weeks. It was exchanged earlier if progression of CMV retinitis occurred. Patient examinations and standard fundus photography were performed at 2-week intervals after the exchange procedure. RESULTS Twenty-six exchange procedures were performed. Twenty-two eyes in 15 patients received a second implant and 4 eyes in 4 patients later received a third implant. Cytomegalovirus retinitis was rendered or maintained inactive in 22 of 23 cases with more than 1 month of follow-up after the second or third implants. Complications after the second implant procedure included transient vitreous hemorrhage in 5 eyes, postoperative inflammation in 1 eye, and retinal detachment in 1 eye. Median visual acuity returned to 20/25 by 28 days and to 20/20 by 42 days. Complications after the third implant procedure included dense vitreous hemorrhage in 3 of 4 eyes. Median survival time after a second implant procedure was 89 days. CONCLUSIONS The initial ganciclovir implant exchange procedure is well tolerated with continued long-term control of CMV retinitis. Multiple reentries through the same wound may be associated with an increased risk for vitreous hemorrhage.
Collapse
Affiliation(s)
- D F Martin
- Department of Ophthalmology, Emory University School of Medicine, Atlanta, Ga., USA
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
41
|
Gibbs D. The college suspended. J R Coll Physicians Lond 1997; 31:332-5. [PMID: 9192340 PMCID: PMC5421038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
A satirical account of the raising of the Royal College of Physicians and its suspension from a balloon for three months is included among Baron Munchausen's later surprising adventures. Portrayals by artists of this flight of fancy involving the College are not widely known. Three pictorial representations of the raising of the College are shown and some of the historical context of the tall tale is given.
Collapse
|
42
|
Affiliation(s)
- L J Francis
- Centre for Theology and Education, Trinity College, Carmarthen, Wales, United Kingdom
| | | |
Collapse
|
43
|
Hill JP, Kao C, Caliebe WA, Gibbs D, Hastings JB. Inelastic X-Ray Scattering Study of Solid and Liquid Li and Na. Phys Rev Lett 1996; 77:3665-3668. [PMID: 10062277 DOI: 10.1103/physrevlett.77.3665] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
|
44
|
|
45
|
Watson GM, Gibbs D, Lander GH, Gaulin BD, Berman LE, Matzke H, Ellis W. X-Ray Scattering Study of the Magnetic Structure near the (001) Surface of UO2. Phys Rev Lett 1996; 77:751-754. [PMID: 10062893 DOI: 10.1103/physrevlett.77.751] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
|
46
|
Detlefs C, Goldman AI, Stassis C, Canfield PC, Cho BK, Hill JP, Gibbs D. Magnetic structure of GdNi2B2C by resonant and nonresonant x-ray scattering. Phys Rev B Condens Matter 1996; 53:6355-6361. [PMID: 9982033 DOI: 10.1103/physrevb.53.6355] [Citation(s) in RCA: 37] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/12/2023]
|
47
|
Hill JP, Sternlieb BJ, Gibbs D, Detlefs C, Goldman AI, Stassis C, Canfield PC, Cho BK. Incommensurate antiferromagnetism in the intermetallic superconductor HoNi2B2C. Phys Rev B Condens Matter 1996; 53:3487-3491. [PMID: 9983862 DOI: 10.1103/physrevb.53.3487] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/12/2023]
|
48
|
Watson GM, Gaulin BD, Gibbs D, Thurston TR, Simpson PJ, Shapiro SM, Lander GH, Matzke H, Wang S, Dudley M. Origin of the second length scale found above TN in UO2. Phys Rev B Condens Matter 1996; 53:686-698. [PMID: 9983020 DOI: 10.1103/physrevb.53.686] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/12/2023]
|
49
|
Everitt BA, Salamon MB, Park BJ, Flynn CP, Thurston T, Gibbs D. X-ray magnetic scattering from nonmagnetic Lu in a DyLu alloy. Phys Rev Lett 1995; 75:3182-3185. [PMID: 10059515 DOI: 10.1103/physrevlett.75.3182] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
|
50
|
Watson GM, Gibbs D, Song S, Sandy AR, Mochrie SG, Zehner DM. Faceting and reconstruction of stepped Au(111). Phys Rev B Condens Matter 1995; 52:12329-12344. [PMID: 9980374 DOI: 10.1103/physrevb.52.12329] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/12/2023]
|